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Background: Technology is evolving to detect and facilitate interpretation of genomic variants 
associated with neurodevelopmental disorders (NDD). With a current diagnostic yield of 25-
40%, exome sequencing (ES) is postured to become a first-tier testing strategy for individuals 
with NDD. However, the psychological sequelae for caregivers of children with NDD following 
genetic testing are still poorly characterized, as are the ways their experiences may differ by the 
type of ES results returned. Past research shows that parental cognitive appraisals related to a 
child’s medical or developmental condition (illness representations) are predictive of behavioral 
and psychological outcomes. This suggests that illness representations may shape caregivers’ 
trajectories following genetic testing, including the process of adapting to their child’s NDD.  
Objective: Our study aimed to characterize the ways in which types of ES results affect 
caregivers’ perceptions of their child’s NDD and uncertainty about their child’s health. We also 
aimed to describe how appraisals of the NDD influence caregivers’ psychological adaptation and 
emotional distress, and to delineate the role of time in these relationships.  
Methods: A total of 1,151 caregivers of children who had undergone ES for an NDD were 
contacted to participate in an online survey. Participants were recruited through two pediatric 
genetics clinics in Baltimore.  
Results: A total of 190 participants completed the survey. Caregiver perceptions of treatment 
control and coherence significantly differed across categories of ES results (positive, negative, or 
VUS), as did overall uncertainty and several domains of uncertainty. Trends in the data indicated 
that caregivers’ greater sense of personal control over their child’s NDD, weaker unfavorable 
feelings associated with the NDD, and receiving a VUS vs. a negative ES result are associated 




predictor for the emotional distress outcomes. No association was found between time and the 
other variables of interest.  
Discussion: This study deepens our understanding of caregivers’ cognitive, affective, and 
adaptive processes following the disclosure of results from ES. Findings from this study carry 
implications for pre- and post-test genetic counseling, enabling clinicians to better tailor 










Lori Erby, PhD, ScM, CGC [advisor, associate investigator] 
Julie S. Cohen, ScM, CGC [co-investigator] 
Amena Smith Fine, MD, PhD [committee member] 
THESIS READERS 
Lori Erby, PhD, ScM, CGC 
Julie S. Cohen, ScM, CGC 
PRINCIPAL INVESTIGATOR 






To my study participants… I cannot overstate my gratitude to each and every one of you for 
taking the time to participate in this research, and for the thoughtful and candid comments you 
shared. Your resilience in navigating adversity is sincerely humbling, and you remind me why I 
want to be a genetic counselor.  
 
To my thesis advisor, Lori… Infinite thanks for your insight, wisdom, patience, and enthusiasm 
in this research endeavor. When I felt lost, you helped lead me back to the path and encouraged 
me to trust myself throughout this process. As a program director, supervisor, mentor, and 
instructor, you make me feel privileged to have spent these several years learning from you.  
 
To my co-investigator, Julie… You truly deserve MVP accolades for the tireless work you 
invested into this project. In the face of obstacles, technological or otherwise, you were always a 
text or phone call away to strategize and press forward. Your commitment to the families you 
work with every day spurred the development of this thesis project, and your passion as a 
clinician and educator inspires me as I enter the field.  
 
To my thesis committee, study team, and admin support… Thank you to Debra, my PI; to 
Amena, my committee member; to Weiyi, Kelsey, Carolyn, Krista, Becky, and Christy; and to 
Susan, Tyler, and Maddie for your assistance throughout this process, for nurturing the seeds of a 
research idea and helping me see it through to completion. A heartfelt thank you to Brian for his 
statistical consultation and guidance.  
 
To the faculty and staff of the JHU/NIH GCTP… Thank you deeply for creating the rigorous 
yet nurturing educational environment that helped shape this thesis. I’ve learned a great deal 
from each of you during this journey. Your support and dedication to the program allowed me to 
make it to this point.  
 
To NHGRI and JHSPH… Thank you for funding this study and for providing administrative 
support, as well as a place to train and develop as a researcher and clinician. 
 
To my colleagues at OHSU and Genetic Alliance… Thank you for providing me ample learning 
opportunities and for laying the stepping stones that led me to the east coast and to this training 
program. Your impact extends far beyond letters of recommendation, and I’m grateful that you 
were part of my journey.  
 
To the GCTP classes of 2019, 2020, 2022, and 2023… Thank you for your consistently 
insightful remarks in seminar and other group discussions that challenged me to think deeply and 
critically. I have felt the love and support from each of you as my cohort confronted and 
accomplished thesis tasks. It’s been a pleasure to be in the company of such warm, funny, and 
smart classmates.  
 
To Stephanie, Liesl, and Carrie… Words cannot capture the love and appreciation I feel for you 
strong, intelligent, kind, and wise women. We started out as complete strangers, but now I can 




between Baltimore and Bethesda, to poker and Bachelor nights, I cherish all the memories we 
created as a cohort over the past 2 ½ years, even though COVID kept us apart for the last stretch. 
I can’t wait to see how you each take the world by storm.  
 
To my family and friends… Thank you to Mom and Jack for your encouragement throughout 
the chapters of my education that culminated in my genetic counseling degree. For you to be 
proud of me is what I’ve always sought. Thank you to Aurora and Dawn for your sisterly 
wisdom and for asking tough questions. To my friends who lent an ear to my frustrations, who 
offered words of reassurance through the rough stretches, and who celebrate this milestone with 
me. There are too many of you to list here, but you know who you are.  
 
To Drew… You witnessed many of my long nights poring over thesis work, and listened to my 
woes with patient understanding and a much-needed dose of grounding humor. You warmly 
welcomed me to Portland when a global pandemic abruptly shortened the distance between us. 
You have never hesitated to tell me how proud you are of my accomplishments, and I hope you 




















TABLE OF CONTENTS 
Abstract…………………………………………………………………………………………..ii 
Acknowledgments……………………………………………………………………………….iv 
List of Tables…………………………………………………………………………………...viii 




Objective and Study Aims……………………………………………………………………...17 
Methods………………………………………………………………………………………….19 
 Study Design……………………………………………………………………………..19 
 Study Sample…………………………………………………………………………….21 
 Measures…………………………………………………………………………………23 
 Statistical Analyses………………………………………………………………………29 
 Ethics Statement………………………………………………………………………….31 
 Funding…………………………………………………………………………………..31 
Results…………………………………………………………………………………………...32 
 Participant Characteristics……………………………………………………………….32 
 Descriptive Statistics……………………………………………………………………..35 
 Factor Analyses…………………………………………………………………………..44 
 Summary Statistics for Key Dependent and Independent Variables…………………….47 
 Internal Reliability of Scales……………………………………………………………..50 




 Aim 1: Influence of ES Results Category on NDD Appraisals………………………….54 
 Aim 2: NDD Appraisals as Predictors……………….…………………………………..59 
 Aim 3: Relationship of Time to NDD Appraisals and Outcomes……………………….72 
 Supplemental Aims: Predictors of Uncertainty……………………………………….....76 
Discussion……………………………………………………………………………………….86 
 Summary of Findings…………………………………………………………………….86 
 Study Limitations……………………………………………………………………….103 
 Practice Implications……………………………………………………………………105 



















1. Power calculation with 10% variance explained……………………………………………...22 
2. Power calculation with 5% variance explained………………………………………..……...22 
3. Description of IPQ-RA subscale interpretations……………………………………………....26 
4. Descriptive statistics and dummy coding scheme for ES results..…………………………….30 
5. Participant demographics……………………….……………………………………………..34 
6. Frequencies for questions on family and caregiving role..……………………………………35 
7. Descriptive statistics for all numerical values….……………………………………………..36 
8. Frequencies for questions related to diagnosis and clinical genetics experience….………….38 
9. Frequencies for ES explanatory questions by diagnostic/non-diagnostic results……………..39 
10. Descriptive statistics and frequencies for child’s symptoms/diagnoses……………………..40 
11. Descriptive statistics and frequencies for child’s difficulties………...….…………………..41 
12. Frequencies for questions related to impact of COVID-19………...….…………………….43 
13. Descriptive statistics for questions related to impact of COVID-19………...…..…………..43 
14. Summary statistics for key independent and dependent scale variables…………………….49 
15. T-test for order effects of PAS display order………………………………………………...51 
16. Logistic regression of dichotomized outcome variables on independent variables………….53 
17a. One-way ANOVA of illness representations and uncertainty by ES results group.………..56 
17b. Post-hoc tests for illness representations and uncertainty by ES results group.……………56 
18. Two-way ANOVA of illness representations…………………..……………………………58 
19. Logistic regression of psychological adaptation on independent variables………………….62 
20. Logistic regression of depression on independent variables………..………………………..65 




22. Logistic regression of stress on independent variables………..…………….………………71 
23. Comparison of logistic regression models with and without time variables………………...74 
24. One-way ANOVA of PUCHS Parts A and B by ES results group………………………….79 
25a. One-way ANOVA of uncertainty by ES results group……………………….…………….79 
25b. Post-hoc tests for comparisons of uncertainty by ES results group………………………...80 
26. Logistic regression of dichotomized uncertainty on predictor variables…..………………...84 

















1. Conceptual framework………………………………………………………………………..15 
2. Histograms: Time since ES and time since CA………………………………………………75 






Genetics of Neurodevelopmental Disorders 
Neurodevelopmental disorders (NDD) are a heterogeneous group of conditions 
characterized by impairments in cognitive, motor, and/or social functioning. Disorders in this 
group typically manifest within the first few years of life and encompass autism spectrum 
disorder (ASD), global developmental delay (GDD), intellectual disability (ID), attention deficit 
hyperactivity disorder (ADHD), communication disorders, motor disorders like cerebral palsy, 
and specific learning disorders (Blesson & Cohen 2019). These disorders lie along a continuum 
of developmental brain dysfunction (DBD) and are diagnosed based on clinical criteria. NDD are 
relatively common in the United States pediatric population, with an estimated prevalence of 1 in 
100 to 1 in 33 (1-3%) for GDD/ID (Blesson & Cohen 2019). A surveillance report by the CDC 
in 2014 found that 1 in 59 (1.68%) children at age 8 have an ASD diagnosis (Baio 2014).   
From an etiological standpoint, NDD are understood to arise from the interaction of 
genetic and environmental factors in the developing brain (Blesson & Cohen 2019). NDD are 
highly heritable, as evidenced by sibling and twin studies; the heritability of ASD is thought to 
be as high as 80 to 90% (Johnson et al. 2011, Sandin et al. 2017). NDD are exceedingly 
genetically heterogeneous, manifesting as a clinical feature of a range of genetic syndromes. 
Genetic testing encompasses a multitude of methods including chromosome microarray analysis 
(CMA) and, more recently, exome sequencing (ES). ES is a test that analyzes the protein-coding 
regions (exons) of nearly all 20,000 genes in the human genome to determine if there are 
changes related to the patient’s phenotype. Generally speaking, genetic testing results are 
categorized as positive/diagnostic (a causative variant was identified), negative/uninformative 




information to determine the variant’s contribution to symptoms). In practice, a VUS is treated 
clinically as a negative result in that no causal diagnosis was obtained.  
As genetic testing technology evolves in sensitivity and sophistication, so improves the 
ability to detect genetic aberrations leading to NDD. Currently, the diagnostic yield of ES for 
NDD is in the range of 25% to >40% (Rossi et al. 2017; Blesson & Cohen 2019). Data suggest 
that the yield is higher for individuals with an ID diagnosis than for those with ASD (Chérot et 
al. 2017). Genetic testing in NDD has the potential to establish a definitive etiological diagnosis, 
provide information about prognosis, guide medical management, determine inheritance pattern 
and associated recurrence risks, and, in some cases, may enable interventions targeted to the 
individual (Johnson et al. 2011; Reiff et al. 2015; Sawyer et al. 2016). Given its demonstrated 
diagnostic success, some researchers uphold ES as a superior first-tier clinical genetic test for 
NDD that may soon supplant CMA (Blesson & Cohen 2019; Srivastava et al. 2019).  
Significance of Genetic Diagnosis for Families of Children with NDD 
Hope for an underlying genetic explanation or diagnosis is oftentimes the driving force to 
pursue genetic testing (Griesemer et al. 2019). A positive test result can truncate a lengthy 
diagnostic odyssey and signify a point of inflection for families seeking the “why” for their 
child’s illness. Adults with undiagnosed conditions seeking exome sequencing for themselves 
have noted that, in addition to uncovering an explanation for the disorder, a genetic diagnosis can 
provide a label, prognostic and treatment information, and pathways to support (Neustadt 2019). 
Evidence suggests that for many families, a conclusive diagnosis promotes acceptance of the 
condition, leads to increased understanding of the child’s capabilities and potential, and 




In the NDD realm, a developmental diagnosis (e.g., global developmental delay) is 
distinct from a genetic or etiological diagnosis (e.g., pathogenic variant in the CUX1 gene). 
Studies of families with ASD show that having a clinical diagnosis of ASD does not preclude an 
interest in genetic testing. The majority of respondents in several quantitative surveys and 
interview-based studies of parents of children with ASD reported that they would follow through 
with testing if it were available for their affected child (Chen et al. 2013; Johannessen et al. 
2017; Hanish et al. 2018; Wagner et al. 2019) or for the child’s unaffected siblings (Narcisa et al. 
2012). In one study, the highest proportion of parents were driven by the possibility to uncover a 
causal explanation for NDD (76%) (Johannessen et al. 2017). In another study, improved quality 
of healthcare and improved access to services were cited as highest perceived benefits of genetic 
testing for ASD (Lucas 2020). Validation, securement of school and early intervention services, 
and reproductive information (e.g., recurrence risks) are recurrent themes of psychological and 
practical benefits derived by parents who receive a genetic diagnosis for their child with NDD 
(Makela et al. 2009).  
Nevertheless, even caregivers of children who get a genetic diagnosis acknowledge the 
sometimes limited utility of genetic testing. Participants in one qualitative study, which 
interviewed parents of children with ASD receiving a diagnosis through CMA, shared that 
positive results had no effect on existing therapeutic services and provided no further 
information than what they already knew about their child through the parenting experience 
(Reiff et al. 2015). Even if a diagnosis is desired, some ambivalence about genetic testing may 
manifest as fear for insurance discrimination and heightened concern for the child’s future 




By that same token, research with families affected by neurological or neuro-
developmental conditions suggests that clinically uninformative results do not universally 
connote disappointment and finality. Data from interview studies reveal that parents’ responses 
to negative ES are layered and nuanced, encompassing gratitude for the experience, longing for 
continued research efforts, and hope for future changes in interpretation of the result 
(Krabbenborg et al. 2016; Skinner, Raspberry & King 2016).  
VUS represent a subset of uninformative results that may be especially frustrating to 
parents, in which a DNA alteration is found but its connection to the child’s disorder is unclear. 
A handful of past studies have examined how these “gray area” results from genetic testing are 
interpreted and internalized by the recipient. For the most part, individuals demonstrate good 
understanding and recall of their VUS results (Jez et al. 2015; Li et al. 2018), and report no 
changes to their child’s care or ability to care for their child (Li et al. 2018). However, past 
research suggests that some people in this group may tend to exaggerate the actionable meaning 
of their VUS and mentally inflate the risk it confers, as was found in a survey of cancer patients 
(Bonner 2017). Parents may hold in tension contradictory interpretations that regard VUS as 
offering an answer and yet little clarification, perhaps exposing some degree of cognitive 
dissonance (Jez et al. 2015; Kiedrowski et al. 2016; Werner-Lin et al. 2017).  
Reports from other disease populations contribute additional insights that have not 
emerged to date from NDD research. A longitudinal interview study with parents of pediatric 
cancer patients found that some interpreted non-diagnostic results from ES absolved them of 
guilt and reassured them that their child and relatives aren’t at higher risk of other genetic 
conditions (Malek et al. 2017). Parents interviewed from cardiac arrhythmia, platelet 




improved disease management, even in the absence of diagnosis or new treatment guidance 
(Werner-Lin et al. 2017). As such, the same type of objective genetic testing result is valuated 
differently across recipients, and these ascribed meanings may well shape how families think 
about their child’s condition.   
Caregiver Illness Representations of NDD 
Cognitions play an important role in individual and relational functioning. Cognitive 
processes directly relate to decision-making, coping behaviors, affective responses, and stress 
(Mire et al. 2018). These relationships have begun to be explored in individuals with NDD. A 
recent study from Israel found that mothers who held coherent, multifaceted beliefs about their 
children with ASD (i.e., those that incorporate both the child’s strengths and challenges) 
displayed greater emotional availability in their parenting relationships (Sher-Censor et al. 2017). 
Other research with families with ASD supports a link between parents’ sense of coherence, 
perceived locus of control, and parenting stress (Sivberg 2002; Hassall, Rose & McDonald 2005; 
Falk, Norris & Quinn 2014). As such, interrogating how caregivers perceive their child’s NDD is 
likely to shed light on the interplay of cognitions and overall well-being in these families.  
Leventhal’s Common Sense Model of Self-Regulation, also known as the Self-
Regulatory Model of Illness Representations, outlines how conceptualization of illness, coping, 
and emotional/behavioral outcomes relate in bidirectional pathways. According to this model, in 
response to illness, individuals construct parallel cognitive and affective representations that then 
influence coping efforts and outcomes (Leventhal et al. 1984, 2001). In Leventhal’s classic 
conceptualization, cognitive illness representations comprise five components: identity, timeline, 
cause, control/cure, and consequences (Moss-Morris et al. 2002). Although NDD are not 




medical conditions (Mire et al. 2018). Parents of children with NDD are embedded in many of 
the same health systems as families navigating a chronic diagnosis. Given that the starting point 
of Leventhal’s model is a health-related stressor, it is reasonable to apply this theoretical 
framework to explore the well-being of parents raising a child with an NDD.  
 Research on NDD illness representations within Leventhal’s proposed dimensions is 
limited. However, the cause dimension is probably the most widely examined. Caregivers’ 
causal attributions for NDD in their children are varied and often multifocal. These attributions 
can include genetics/heredity, divine will, neurostructural differences, toxins in vaccines, and 
environmental pollutants. In one study, parents who categorized their child’s ASD as regressive 
and witnessed a loss of skills were more likely to endorse environmental or external mechanisms 
as responsible (Goin-Kochel et al. 2015). Importantly, there is evidence that causal beliefs about 
ASD predict choice of treatment and behaviors related to health management (Al Anbar et al. 
2010; Dardennes et al. 2011). Along the timeline dimension, a quantitative study using a 
nationally representative, CDC-administered survey of caregivers of children with 
developmental conditions found a positive association between endorsement of chronicity (“my 
child’s condition is lifelong”) and reported peer and conduct challenges among their children 
with ASD (Haney, Houser & Cullen 2018). Parents of children with ASD who participated in a 
mixed methods study expressed a range of views on the timeline/course and controllability of 
their children’s symptoms, including hopes for a cure for ASD and a societal shift toward greater 
acceptance. Contrary to the researchers’ hypothesis, the study found a positive association 
between parents’ perceived personal control over their child’s symptoms and levels of depression 




 Biomedical information, such as genetic testing results, can directly shape an individual’s 
illness representations. This point was illustrated by Reiff and colleagues (2017) in a mixed 
methods study of parents of children with ASD (N = 57). The study assessed differences in 
beliefs about etiology and prognosis among parents who did and did not receive 
diagnostic/pathogenic CMA results. Although parents did not diverge significantly in their causal 
attributions, those whose children’s testing uncovered a pathogenic variant perceived ASD as 
more permanent than those in which no genetic diagnosis was made (VUS or negative result). 
Across testing outcome groups, permanence ratings were positively correlated with perceived 
genetic contribution to ASD. Participant interviews revealed that parents whose children had 
negative or uncertain results tended to construe their children’s symptoms as more controllable 
(modifiable) and amenable to improvement (Reiff et al. 2017). 
 As indicated in the studies outlined above, signs of a link between conceptualizations of 
NDD and genetic diagnosis have begun to surface, though evidence is still sparse and primarily 
focused on ASD over other types of NDD. To our knowledge, there are no studies that support 
the notion that genetic testing method (CMA vs. ES) differentially affects parental perceptions of 
their child’s condition. However, it could be argued that children who get ES for an NDD 
indication have likely endured a longer wait to find a genetic cause than children who have just 
had CMA, and this wait time could influence perceptions. The current study attempted to support 
and expand on Reiff and colleagues’ (2017) findings in a related but distinct caregiver sample 
(ASD + CMA testing vs. NDD + ES testing) to illuminate the downstream effects of NDD 
genetic testing. The sample in the current study reflected a growing number of families 
undergoing ES, which is projected to be the first-line test for NDD in the near future (Blesson & 




that of the sample in Reiff et al.’s study, which we hoped would allow us to capture a broader 
and perhaps more generalizable range of caregiver experiences within which to discern 
meaningful patterns between ES and NDD representations. We anticipated that any relationships 
found in the current study would be directionally congruent to those in the study by Reiff and 
colleagues.   
Psychological Adaptation and Distress in NDD Caregivers  
Adaptation is conceptualized as a “dynamic and multidimensional process of coming to 
terms with the implications of a health threat and the outcomes of that process” (Biesecker et al. 
2013). This definition is rooted in Taylor’s theory of cognitive adaptation (1983), which 
postulates that adaptation centers on three interrelated themes: searching for meaning, regaining 
mastery, and restoring self-esteem. It is through these processes that one can begin to appreciate 
the personal significance of the health threat (referenced in Lim & Chong 2017). Adaptation is 
sometimes referred to as adjustment or acceptance in other studies (Biesecker & Erby 2008), and 
comprises processes of positive inner growth and benefit finding (Lim & Chong 2017; 
Griesemer et al. 2019). Given that facilitating adaptation is regarded as an integral goal in 
genetic counseling work (Biesecker & Erby 2008), it is essential within the practice to better 
understand what upstream factors promote or hinder longer-term adaptation, in order to intervene 
where possible.  
In their seminal Transactional Model of Stress and Coping, Lazarus & Folkman (1984) 
posit that adaptation is an outcome of coping, following primary and secondary appraisals of a 
stressor. The manner in which parents cope through problem management, emotional regulation, 
and meaning-making can either foster or hamper movement toward adaptation. This component 




NDD literature. Coping strategies like reframing and positive reappraisal (both part of meaning-
based coping), self-empowerment, and focus on family integration have been linked to reduction 
of parental stress in several studies of children with developmental disabilities (Jones & Passey 
2004; Werner & Shulman 2013; Minnes, Perry & Weiss 2015). Parental coping strategies can 
also be dynamic, evolving over time as the child ages (Gray 2006). Importantly, research in 
families with NDD supports coping response as a robust predictor of adaptation, whereas 
characteristics of the child’s condition are not reliably predictive (severity of symptoms, level of 
functioning, maladaptive behaviors) (Pianta et al. 1996; Minnes, Perry & Weiss 2015).  
Although psychological well-being in parents of children with NDD has garnered 
research attention (e.g., Cramm & Nieboer 2011; Werner & Shulman 2013), direct measurement 
of adaptation in this population is scant. However, a construct analogous to adaptation, used by 
several researchers, is parents’ resolution (acceptance) of a clinical diagnosis. Resolution refers 
to successful integration of pre- and post-diagnosis internal representations of the child and the 
self (Milshtein et al. 2010). Milshtein and colleagues found that among mothers in their sample, 
the only significant correlate of resolution status was perceived negative impact of the child’s 
ASD diagnosis on the family.  
Like adaptation, psychological distress and well-being are also important constructs for 
examining how families assimilate the challenges of NDD. These indicators of psychological 
adjustment have been captured through outcomes commonly evaluated in social science 
research, including quality-of-life measures. Raising a child with a disability poses cognitive, 
emotional, and physical demands on the family (Milshtein et al. 2009). Many studies have 
demonstrated higher rate of stress, depressive symptomology, and poor psychological well-being 




Cheshire, Barlow & Powell 2010; Cantwell et al. 2015; Padden & James 2017; Stewart et al. 
2017; Lee & Chiang 2018). A 2010 review showed that parents of children with intellectual and 
developmental disabilities frequently encounter chronic stressors, which may predict adverse 
physical and psychological health outcomes (Miodrag & Hodapp 2010). There is evidence to 
suggest that parents of children with ASD are more likely to experience anxiety disorders 
(Conner, Maddox & White 2013) and clinically significant psychological distress (Gatzoyia et 
al., 2014). Furthermore, a meta-analysis (Hayes et al. 2013) and a cross-sectional study 
(AlAnsari & Jahrami 2018) found that parents of children with ASD experienced greater stress 
than parents raising children with typical development or with other types of NDD. Importantly, 
parenting stress has been associated with lack of diagnosis resolution, implying that persistent 
stress is inversely related to adaptation, potentially as an indicator of ineffective coping in the 
parent dyad (Sheeran, Marvin & Pianta 1996).  
Evidence also supports an influencing role for illness representations in psychological 
distress in parents of children with ASD. Gatzoyia and colleagues (2014) found that parents with 
strong beliefs about the chronicity and consequences of their child’s ASD had more severe 
depressive symptoms and general psychological distress. This NDD-specific result is consistent 
with conclusions from a prior meta-analytic review (Hagger & Orbell 2003). This review 
compiled 45 empirical studies based on Leventhal’s Common Sense Model of Illness 
Representations, identifying seven categories of coping strategies and six categories of health 
outcomes. Hagger and Orbell found that the illness representation dimensions of consequences, 
timeline, and identity were all significantly negatively associated with psychological well-being, 
as well as role and social functioning. In addition, the various dimensions of illness 




related to expressing emotions and problem-focused coping, while perceived chronicity was 
related to avoidance and emotional coping. This meta-analysis supports a role for illness 
representations not only in Leventhal’s theoretical model, but also Lazarus and Folkman’s 
conceptualization of coping and adaptation.  
Time in Illness Appraisals and Adaptation 
Few studies have examined the role of time in influencing the variables in the pathway of 
interest, namely, illness representations and psychological adaptation. Interestingly, evidence 
from a quantitative multi-time point study points to the shifting salience of genetic test results on 
parental cognitions outside of the context of NDD. This study found that at 12 months, parents 
who received a VUS on a prenatal CMA perceived their children as less competent than parents 
who received normal/likely benign results. However, this difference vanished at 36 months 
(Desai et al. 2018). One would imagine that illness representations would change with time, 
particularly those related to the chronic and cyclical nature of the condition. Time and experience 
generate data points that bolster or threaten ideas that an individual has constructed about the 
condition. However, no research to date has investigated this assumption within NDD 
populations.  
Adaptation is a process that occurs over the course of time, and indeed, most individuals 
do adapt to the challenges associated with a genetic condition or risk (Biesecker, Peters & Resta 
2019). No studies have examined through longitudinal or cross-sectional approaches how 
psychological adaptation changes over time or relates to time since diagnosis or testing. Past 
research with parents of children with chronic health conditions generally indicates that 
resolution status is not a function of time since diagnosis (Popp et al. 2014; Milshtein et al. 




between parents of children with type 1 diabetes or asthma who were unresolved, and those who 
were resolved. In this study, time since diagnosis ranged from 18 to 36 months, and 41% of 
parents were unresolved with their child’s diagnosis at the time of study participation. 
Furthermore, several longitudinal studies have found that resolution is unstable among parents of 
children with ASD and CP, fluctuating rather than progressively increasing (Yirmiya et al. 2015; 
Rentinck et al. 2010). Popp suggests that resolution may be a coping strategy in response to 
stress, and thus may not even be a viable proxy for psychological adaptation as the current study 
examines it (Popp et al. 2014).  
Uncertainty in NDD Caregiving  
 Uncertainty permeates the experience of living alongside a chronic condition or 
disability. For these families, feelings of uncertainty can stem from fluctuations in the child’s 
health and functional status, transitional periods of renegotiating independence and caregiving 
roles, questions of prognosis and life expectancy, changes to treatment access or eligibility, and 
anticipated loss of support sources (Pryce et al. 2017; Jivanjee, Kruzich & Gordon 2009; 
Dodgson et al. 2000). From a theoretical standpoint, uncertainty has been extensively described 
by Mishel, who defines it as “the inability to structure the meaning of illness related events” 
(Mishel 1988, 1990). According to her theory, uncertainty is not a desirable or undesirable state 
per se, but is appraised as either a danger or an opportunity (Mishel 1990). More recently, Han 
and colleagues (2011) have elaborated on Mishel’s work in a taxonomy of uncertainty in 
healthcare, positing that the nuanced experience of uncertainty can be mapped along three 
dimensions: issue (scientific, practical, personal), source (probability, ambiguity, complexity), 




In the realm of clinical genetics, desire to alleviate illness-related uncertainty can be a 
potent motivator for genetic testing (Baum, Friedman & Zakowski 1997; Khan et al. 2016). 
Indeed, research findings imply that a diagnosis may confer psycho-emotional advantages in the 
process of adapting to living with a condition in the family. Parents of children with undiagnosed 
medical conditions have been found to have lower perceived social support, hope, coping 
efficacy, and psychological adaptation, compared to parents of diagnosed children (Yanes et al. 
2017). Similarly, mothers of children with etiologically unexplained intellectual disability scored 
higher on measures of anxiety, emotional strain, and worry, compared to mothers of children 
with Down syndrome or no disability (Lenhard et al. 2005). That said, even when a genetic 
diagnosis is known, uncertainty often persists, especially when knowledge about a condition is 
lacking due to its novelty or rarity. In contrast to the findings described above, qualitative 
investigations suggest that parents who obtain a diagnosis for their child may have similar 
expressions of and responses to uncertainty as those without a diagnosis (Hayeems et al. 2016; 
Reiff et al. 2012). Much of this uncertainty centers on the child’s current and future health, and 
prognostic information (Hayeems et al. 2016; Inglese et al. 2019). Furthermore, there is evidence 
of association between higher uncertainty and higher quality of life in ASD families, partially 
mediated by the parental sense of mastery over the disorder (Garrett 2014). It appears that 
characteristics of uncertainty and its appraisal, not just its presence or absence, are important 
determinants in adaptation following genetic testing. 
It is suggested that uncertainty is related to parental cognitions about their child’s illness 
and constitutes another layer of appraisals, although it is not explicitly captured in validated 
measures of illness perceptions (i.e., the Illness Perception Questionnaire (IPQ)). Madeo and 




could be construed as analogous to the consequences dimension of illness representation (Madeo 
et al. 2012). Uncertainty also bears on coping strategies (Macnamara 2014) and interacts with 
caregivers’ dispositional factors like optimism and hope (Macnamara 2014; Bell et al. 2019) to 
influence how families come to terms with a child’s condition. Uncertainty in children’s illness 
has also been linked to adverse psychological outcomes including depression, anxiety, and 
cognitive disturbances (Yanes et al. 2017). Given this established relationship between 
uncertainty, adaptation, psychological distress, and potentially illness representations, it is 
important to take uncertainty perceptions into account by studying the impact of pediatric-onset 
NDD and genetic testing.  
Conceptual Framework 
As alluded to in the preceding section, Leventhal’s Self-Regulatory Model of Illness 
Representation (SRMIR) and Lazarus and Folkman’s Transactional Model of Stress and Coping 
(TMSC) jointly form the basis of the present study’s conceptual framework. In both of these 
models, a stressor or stimulus (such as results from ES) is appraised by an individual; these 
appraisals have cognitive and affective dimensions. We conceptualize these appraisals of ES 
results as bearing on primary appraisals of the child’s NDD (illness representations and 
uncertainty), which in turn guide coping mechanisms. Per the TMSC, this coping process leads 
to adaptation and other downstream psychological and adverse affective outcomes in the form of 
anxious and depressive symptoms.  
Although it doesn’t appear in the classic SRMIR and TMSC theoretical models, 
uncertainty may act as another cognitive force shaping illness representations. Previous research 
has integrated Mishel’s characterization of uncertainty (1988) as a process intersecting with 




time that has elapsed since the genetic testing is expected to affect the coping process and 
consequently psychological adaptation and distress. 
 
 
Figure 1. A conceptual framework for the influence of exome sequencing results on representations of 
NDD and psychological adaptation. In this proposed model, the category of the child’s ES results 
contributes to caregivers’ psychological adaptation by shaping illness representations related to the NDD. 
Time also plays a role in appraisals and outcomes. ES = exome sequencing; Pos = positive; VUS = 










To date, we are unaware of any studies that have proposed and tested interlocking 
relationships between genetic testing outcomes, illness representations, and psychological 
adaptation among parents of children with NDD. Studies that have examined pieces of the 
proposed adaptation pathway have largely depended on qualitative methodology (Dale, Jahoda & 
Knott 2006; Gray 2006; Kiedrowski et al. 2016; Krabbenborg et al. 2016; Reiff et al. 2017; 
Skinner, Raspberry & King 2016; Werner-Lin et al. 2017; Li et al. 2018). Furthermore, the bulk 
of existing research has focused on only one type or group of diagnoses within NDD, 
predominantly ASD, which limits generalizability of findings. By surveying parents of children 
across the NDD spectrum, we hope to capture a breadth of parent experiences at different post-
test time points and elucidate relationships across a number of measures. As genetic testing for 
NDD increasingly moves toward utilization of ES, it will be of paramount importance to gain 
insight into the cognitive and emotional trajectories of families as they adapt to a definitive 
genetic diagnosis or lack thereof. We hope this study will contribute to the development of more 
effective and timely interventions for families susceptible to poorer psychological adjustment 











OBJECTIVE AND STUDY AIMS 
 Empirical studies of caregivers to children with NDD has largely focused on indicators of 
psychological and emotional wellbeing. Some studies have also linked these outcomes to 
caregivers’ cognitive and emotional representation of their child’s condition. The current study 
aims to connect these pieces to genetic results from ES, which we propose may be an upstream 
predictor of illness appraisals, coping, and adaptation. We also sought to understand how ES 
results contributed to caregivers’ uncertainty related to their child’s NDD. By expanding on the 
existing knowledge base in these domains, we hope genetic counselors and other healthcare 
providers can better anticipate the needs of families and tailor their counseling work accordingly.  
Aim 1: To assess how type of result from child’s exome sequencing (ES) relates to caregiver 
illness representations of NDD and uncertainty.  
Hypothesis 1.1: Certain illness appraisals of NDD among caregivers will be sensitive to genetic 
testing and will differ based on the category of ES results their child received: 
• Permanence (chronicity) will be highest in the positive ES results group, followed by 
the VUS group, then the negative ES results 
• Controllability (personal and treatment control) will be highest in the negative ES 
results group, followed by the VUS group, then the positive ES results group 
• Coherence will be highest in the positive ES results group, followed by the VUS 
group, then the negative ES results group 
• Attribution to a genetic cause will be highest in the positive ES results group, 




• Uncertainty about their child’s health will be highest in the VUS group, followed by 
the negative ES results group, then the positive ES results group  
Hypothesis 1.2: Caregiver uncertainty about their child’s condition will moderate the relationship 
between type of ES results and illness representations. 
Aim 2: To describe the extent to which illness appraisals among caregivers of children with 
NDD predict psychological adaptation and emotional distress. 
Hypothesis 2.1: Caregivers who view their child’s NDD as more permanent, less controllable, 
less coherent, more emotionally distressing, carrying greater consequences, and/or experience 
greater uncertainty about their child’s health will have poorer psychological adaptation and 
greater emotional distress.  
Aim 3: To examine the role of time in caregivers’ psychological adaptation and emotional 
distress.   
Hypothesis 3.1: Caregivers who have greater temporal distance from genetic testing will be more 
adapted to their child’s NDD than those for whom testing was more recent, controlling for other 
predictor variables.  











 Our cross-sectional study used a web-based survey instrument to examine illness 
representations and psychological adaption in caregivers of children with NDD. Prospective 
participants were recruited in a targeted manner through genetics clinics at two medical 
institutions in Baltimore, Maryland: Kennedy Krieger Institute (KKI) and Johns Hopkins 
Medicine (JHM). Participants completed an online survey comprising several validated measures 
of constructs within the conceptual framework. The survey was built using the Qualtrics 
platform, licensed for use by students at Johns Hopkins Bloomberg School of Public Health. 
Estimated time to complete the survey was 15 to 25 minutes. Participants who completed the 
survey were eligible to receive a $5.00 electronic gift card.  
Pilot Study 
 A pilot study was conducted before the main study was distributed. The purpose of this 
pilot study was to ensure that the questions and instructions on the survey were clear to 
participants, as well as to provide an estimated time to complete the survey. Pilot participants 
were asked to complete the survey and provide feedback by responding with any questions or 
comments about the survey. Two caregivers who met inclusion criteria for the main study were 
recruited from the KKI Department of Neurology and Developmental Medicine by genetic 
counselor Julie Cohen and participated in the pilot study. The pilot study resulted in no changes 






Six study co-investigators at KKI and JHM (Julie Cohen, Rebecca McClellan, Weiyi Mu, 
Krista Schatz, Kelsey Stauff Guthrie, and Carolyn Applegate), who are all clinical certified 
genetic counselors, provided the student investigator with access to logbooks of their patients. 
Visit dates for the logbooks ranged from 2012 to 2020. These included patients for whom ES 
was ordered. The student investigator then analyzed patient charts through the electronic medical 
record to determine if the patient, and by extension their caregiver(s), met eligibility 
requirements for the study. If the patient met any of the following conditions, they were omitted 
from recruitment: 1) deceased, 2) non-English speaking, as denoted by an interpreter request in 
the chart, 3) no documentation of ES results received from the lab, 4) genetic counseling note did 
not include NDD in the indication for testing or reason for referral, 5) autonomous (no caregiver 
or guardian listed), 6) duplicate contact (same patient or affected sibling of a patient already 
listed for contact), 7) secondary (incidental) finding was returned on ES.  
If a patient met inclusion criteria, the contact email address and/or home address listed in 
the electronic medical record was recorded. Once a prospective participant list was compiled 
from each genetic counselor’s patient pool, study invitations were sent out by email or physical 
mailing (see Appendix D). For those patients that had an email address on file, a mail merge was 
created with the study invitation and deployed in batches. For KKI patients, the student 
investigator emailed the study invitations from an email address created specifically for the 
study, NDD-Genetics-Study@kennedykrieger.org. For JHM patients, each co-investigator 
emailed the study invitations to her respective list of patient contacts.  
Following survey completion, electronic gift cards were distributed to respondents who 





Study participants were self-identified primary caregivers to an individual who 
underwent genetic counseling and clinical exome testing between 2012 and 2020, and had these 
test results returned to them. The affected individuals were living and had a documented clinical 
diagnosis of a pediatric-onset NDD, either isolated or part of a broader diagnosis or disease 
presentation, as the indication for exome sequencing. For the purposes of this study, 
“neurodevelopmental disorder” encompassed global developmental delay (GDD), intellectual 
disability (ID), autism spectrum disorders (ASD), and cerebral palsy (CP). Inclusion criteria also 
specified that respondents be at least 18 years of age. There were no eligibility restrictions based 
on demographics such as race, ethnicity, sex, or gender.  
The proposed sample size for the study was 200 individuals. Two power calculations for 
linear bivariate regression analyses were conducted to specifically assess the relationship 
between illness representations and psychological adaptation (Aim 2) (see Tables 1 and 2). 
Holding alpha at 0.05 and power at 0.80, a small (r2 = 0.01) to medium (r2 = 0.09) effect size for 












Table 1. Sample size required to achieve 80% power to detect small and medium effect sizes 






























1 348 0.05 12 2 10 0.80 
2 171 0.05 12 4 10 0.80 
3 136 0.05 12 5 10 0.80 
4 83 0.05 12 8 10 0.80 
5 54 0.05 12 12 10 0.80 
 
 
Table 2. Sample size required to achieve 80% power to detect small and medium effect sizes 






























1 367 0.05 12 2 5 0.80 
2 181 0.05 12 4 5 0.80 
3 144 0.05 12 5 5 0.80 
4 88 0.05 12 8 5 0.80 











A copy of the complete survey instrument is provided in Appendix E.  
Eligibility Screening 
 After reading the informed consent form (see Appendix C), participants were asked a 
series of five questions as an additional precautionary measure to ensure that they fulfilled 
inclusion criteria. These questions were: 1) “Are you the primary caregiver to an individual with 
a neurodevelopmental disorder?”, 2) “Is this individual still living?”, 3) “Are you 18 years or 
older?”, 4) “Were you invited to participate in this study by a genetics provider at Kennedy 
Krieger Institute or Johns Hopkins Medicine?”, and 5) “To your knowledge, has anyone else in 
your household already completed this survey?” If they responded “No” to Q1, Q2, Q3, and/or 
Q4, they were automatically redirected to the survey end page. Participants who responded 
“Yes” to Q5 were also redirected.  
Demographics 
 Participants were asked a series of nine close-ended, multiple-choice questions about 
their current age, gender, race, ethnicity, marital status, employment status, and level of 
education.  
Impact of COVID-19 
Participants were asked a series of six close-ended, multiple-choice questions about how 
the global COVID-19 (novel coronavirus) pandemic affected their day-to-day life, including 
shelter-in-place status, caregiving activities, financial situation, and continuity of services for 
their child. These questions were designed to help determine analytically if COVID-related 




Respondent and Family Characteristics  
Participants were asked 14 short open-ended, multiple-choice, and binary yes/no 
questions about their caregiving role, their affected child, the child’s medical and behavioral 
history, and other family members. Respondents were instructed to answer all survey questions 
for their oldest child with NDD who had undergone ES. One of these questions, “Did you 
already receive results from your child’s exome testing?”, served as an additional screener 
question. If participants responded “No” to this question, they were automatically redirected to 
the survey end page.  
Exome Sequencing 
Participants were asked five short open-ended, multiple-choice, and 5-point Likert scale 
questions (1 = “not at all” to 5 = “completely”) about the results from ES and the perceived 
extent to which the test result explains their child’s neurodevelopmental differences. A central 
predictor variable, “time since ES,” was calculated by subtracting the child’s reported age at the 
time of ES from the child’s current age. “Time since clinical attention” was calculated by 
subtracting the child’s reported age at the time the caregiver sought out a specialist from the 
child’s current age. 
NDD Characteristics  
Participants were provided a list of eight developmental diagnoses and NDD-related 
symptoms and asked to indicate which described their child. This list was developed for the 
current study and selected based on definitions of NDD in the literature (e.g., American 
Psychiatric Association 2013; Srivastava et al. 2019) and in consultation with genetic counselor 
and committee member Julie Cohen. A total score was calculated by tallying the number of 




In addition, participants were provided a list of 19 cognitive, communication/ 
interpersonal, mobility, sensory, and self-care difficulties items and asked to indicate which 
described their child. These items were derived from a validated measure of disability in 
childhood, About My Child—19-Item (AMC-19) (Williams et al. 2018). Finally, they were 
asked to report on the relative seriousness of their child’s condition on a multiple-choice item.  
Revised Illness Perception Questionnaire for Autism (IPQ-RA) (Al Anbar et al. 2010, Mire et al. 
2018) 
Participants were asked to respond to 57 items on a version of the Revised Illness 
Perception Questionnaire (IPQ-R) adapted and validated for parents of children with autism. The 
IPQ-RA consists of nine subscales each corresponding to a specific dimension of cognitive and 
emotional representations: 1) Identity, 2) Timeline: Acute/Chronic, 3) Consequences, 4) Personal 
Control, 5) Treatment Control, 6) Illness Coherence, 7) Timeline: Cyclical, 8) Emotional 
Representation, and 9) Causal Beliefs. For this study, the IPQ-RA was modified slightly to omit 
the Identity subscale, as features of the child’s disorder were evaluated in a preceding section of 
the survey. Furthermore, Timeline: Acute/Chronic is referred to as “Chronicity” and “Timeline: 
Cyclical” as “Cyclicity” from this point forward for brevity. Items on all IPQ-RA subscales 
(except Causal Beliefs, see below) were measured on a 5-point Likert scale (1 = “strongly 
disagree” to 5 = “strongly agree”). Items 1, 4, 15, 17, 18, 19, 23, 24, 25, 26, 27, and 36 were 
reverse scored. A total score for each subscale except Causal Beliefs was calculated by summing 
the responses to the items within that subscale.  
The causal beliefs subscale consists of 18 attributional items, which in scoring are 
grouped into categories of “Personal attribution,” “Environmental attribution,” and “Hereditary 




“Hereditary attribution” grouping was utilized, which consists of one causal attribution item, 
“Genetics / heredity”.  
Table 3. Description of IPQ-RA subscale interpretations† 
IPQ-RA Subscale Higher scores indicate that caregivers: 
Timeline: Acute/Chronic 
(Chronicity) 
Perceive symptoms of their child’s NDD as chronic 
Timeline: Cyclical 
(Cyclicity) 
Believe their child’s NDD is cyclical and unpredictable 
Consequences Experience/perceive negative consequences of NDD 
Personal control Perceive they have control over their child’s NDD 
Treatment control Perceive they have control over treatments for their child’s NDD 
Coherence Believe they understand their child’s NDD 
Emotional representation Experience negative feelings associated with their child’s NDD 
† Adapted from Mire et al. (2018) 
 
Parental Uncertainty about a Child’s Health Scale (PUCHS) (Macnamara 2014)  
Participants were asked to respond to a series of 30 items about their perceptions of 
uncertainty related to their child’s NDD. The PUCHS measures several dimensions of parental 
uncertainty and weights each dimension by importance. In Part A, each of 15 uncertainty items is 
measured on a 5-point Likert scale ranging from -2 = “strongly disagree” to 2 = “strongly agree.” 
Each item has the same stem “Having a genetic diagnosis or not having a diagnosis for my 
child’s condition leaves me…” and asks respondents how much they agree with “insufficiently 
prepared to participate in treatment decisions for my child,” “unsure what to tell relatives about 
risks to their children,” “uncertain about the meaning of my child’s life,” etc. The prompt/stem 
for Part A was altered from the original PUCHS to accommodate participants who either have or 
lack a diagnosis. The original prompt read: “Not having a diagnosis for my child’s condition 
leaves me…”. Additionally, for analytic ease and clarity of reported data, PUCHS scores were 




a score of -2 became 0, a score of -1 became 1, and so forth. A score of 0 indicated lowest levels 
of uncertainty, while a score of 4 indicated highest levels of uncertainty. A similar re-coding 
scheme has been utilized in the past by Yanes and colleagues (2017). 
In Part B, each importance item is also measured on a 5-point Likert scale ranging from 1 
= “unimportant” to 5 = “important”. The weighted total uncertainty score for each individual is 
calculated by weighing each uncertainty item by its corresponding importance and then dividing 
by the sum of the importance items (Macnamara 2014, Yanes et al. 2017). As described by 
Umstead et al. (n.d.), “Higher scores indicate a participant perceives greater uncertainty in 
important domains related to his or her child’s condition.”   
The survey was deployed to participants with the original version of the PUCHS with 15 
weighted items (30 total questions), as presented in the validation study by Umstead et al. (n.d.). 
The authors originally proposed seven dimensions of uncertainty: Diagnostic, Medical 
Management, Future, Reproductive, Family, Social, and Existential. Following their exploratory 
factor analysis, they reported that three weighted items were removed during model refinement 
due to weak correlation to other scale items: 4/b, 14/b, and 15a/b. The latter two weighted items 
comprised the entire Existential subscale. However, other contemporaneous and subsequent 
publications that have utilized the PUCHS differ in their factor loadings and delineation of 
uncertainty domains (Macnamara 2014; Yanes et al. 2017; Bell et al. 2019). Given these 
discrepancies, we left all original PUCHS items in the survey that was distributed to participants 







Psychological Adaptation Scale (PAS) (Biesecker et al. 2013) 
Participants were asked a series of 20 items through the Psychological Adaptation Scale 
(PAS) to assess how they think about how the experience of caregiving for a child with NDD has 
made a difference in their lives. The PAS includes four subscales containing five questions each: 
1) Coping Self-Efficacy, 2) Self-Esteem, 3) Social Integration, and 4) Spiritual Well-Being. Each 
item begins with the stem “Being a caregiver of an individual with an NDD has…”. Items are 
measured on a 5-point Likert scale ranging from 1 = “not at all” to 5 = “very much.” The score 
for each subscale was calculated by taking the average of items with the subscale. An overall 
score was calculated by averaging the four subscale scores. Higher scores reflected greater 
adaptation to the child’s NDD.  
To minimize framing effects or recency bias related to eliciting thoughts about 
uncertainty or adaptation, participants were randomized by the survey software to complete 
either the PUCHS or the PAS first, after the IPQ-RA and before the DASS-21 (see below). The 
order of all other survey sections remained static. 
Depression Anxiety Stress Scales – 21 Items (DASS-21) (Lovibond & Lovibond 1995) 
Participants were asked a series of 21 questions that assessed their experience of various 
emotional and behavioral symptoms of stress, anxiety, and depression in the past week. Each 
item is measured on a 4-point Likert-format scale ranging from 0 (did not apply to me at all) to 3 
(applied to me very much or most of the time). The scores for depression, anxiety, and stress 
were calculated by summing the relevant items for each.  
Open-Ended Responses 
Finally, participants were asked five questions to reflect on their experiences of exome 




share additional thoughts or comments with the study team. Participants were instructed not to 
disclose any identifying information about their child. These qualitative questions were included 
to serve descriptive purposes and to help contextualize surprising, inconsistent, or non-
significant results from the quantitative analyses. 
Statistical Analyses 
 Responses from the survey were analyzed to examine relationships between three main 
groups of predictors and outcomes. The first aim of the study was to examine how ES results 
relate to primary appraisals about the child’s NDD. In our study, primary appraisals were illness 
representations and uncertainty about the child’s NDD. These relationships were assessed using 
a series of one-way and two-way analyses of variance (ANOVA). The second aim of the study 
was to examine how NDD appraisals relate to psychological adaptation and emotional distress. 
Emotional distress constituted symptoms of depression, anxiety, and stress. These relationships 
were assessed using a series of binomial logistic regression models. The third aim of the study 
was to examine the relationship of time to the remaining variables. These relationships were 
assessed using a series of binomial logistic regression models. Statistical analyses were 
completed using IBM SPSS Version 25.  
Descriptive Statistics 
 Frequencies and percentages were calculated to characterize the population based on 
demographics as well as characteristics of the ES testing, the child’s diagnosis, the caregiver’s 
role, and family structure. Mean values and standard deviations were calculated for 
numerical/scale variables, such as child’s current age and age at testing. In addition, mean values 




population based on illness representations, uncertainty about the child’s condition, anxiety, 
depression, stress, and psychological adaptation.  
 ES results category was transformed into two dummy variables for use in subsequent 
regression analyses, with the VUS group serving as the reference group. Preliminary descriptive 
analyses were run to examine the relationship of ES levels with psychological adaptation and 
uncertainty. Because VUS emerged as an extreme for both variables (either highest or lowest 
mean out of the three ES results groups), it was selected as a suitable reference group. The 
dummy coding scheme for creating two new variables is shown below in Table 4.  
Table 4. Descriptive statistics and dummy coding scheme for ES results [N = 190] 
Outcome Variable ES Results Level M SD 
Psychological adaptation  
(PAS) 
Positive 3.81 .68 
Negative 3.56 .79 
VUS 3.88 .73 
Uncertainty  
(PUCHS (26 item)) 
Positive 1.32 .85 
Negative 1.76 .85 
VUS 1.92 .87 
 
OutcomeES x1_RefVUS x2_RefVUS 
Positive = 1 1 0 
Negative = 2 0 1 
VUS (reference) = 3  0 0 
Note: x1_refVUS = difference in means between VUS and positive groups; x2_refVUS = difference in 












 This research study was determined to be exempt from human subjects review by the 
Institutional Review Board of the Bloomberg School of Public Health, Johns Hopkins University 
(JHSPH IRB #12189), on July 2, 2020. Participants were informed that reading a description of 
the study and clicking “I accept” to proceed to survey indicated their consent to the study. 
Documentation of written consent was waived by the JHSPH IRB. See Appendix C for 
informed consent language.  
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 A total of 1,151 prospective participants were contacted by email or physical letter 
between September 2020 and December 2020. Of those who were invited to participate, 999 
(86.8%) had children tested through Kennedy Krieger Institute and 152 (13.2%) had children 
tested through Johns Hopkins Medicine. A total of 254 (22.1%) respondents started the survey 
and 24 people did not continue beyond the eligibility questions either because they voluntarily 
quit, or because they were not eligible to proceed. Ten further respondents were directed to the 
end of the survey after responding negatively to screener Q3 (“Did you already receive results 
from your child’s exome testing?”). 
Conservative requirements were set for the four validated quantitative measures such that 
responses were only included in analyses if participants completed at least 50% of the items of 
each subscale within the IPQ-RA, PUCHS, PAS, and DASS-21. The exact cutoff depended on 
the number of questions in each subscale. Thirty responses were excluded for failing to meet 
these requirements. For those who were retained, person mean imputation was utilized to impute 
missing data within the scales given each respondent’s answers to other items in the subscale. At 
least one data point was imputed for 19 cases. The final sample comprised 190 eligible 








 Of the 190 final participants, the majority were female (88.9%), white (85.3%), and non-
Hispanic or Latinx (95.3%). The average age of participants was 43.8 years. The greatest 
proportion of respondents reported that they were employed full-time currently (49.5%) and 
before (54.7%) the COVID-19 pandemic. Respondents were highly educated, with 32.1% 
reporting a college degree and 41.1% reporting a graduate degree. Most (80.6%) were married. 
Demographic characteristics are summarized in Table 5 below. Characteristics of the excluded 
respondents are not shown, but were comparable to characteristics of participants who were 






























Table 5. Participant demographics [N = 190] 
 
Variable Response N % 
Gender Male 21 11 
 Female 169 89 
Race (check all that apply) American Indian/Alaska Native 1 0.5 
 Asian 10 5.2 
 Black/African American 16 8.4 
 White 162 85.3 
 Other 10 5.2 
Ethnicity Hispanic/Latinx 9 4.7 
 Non-Hispanic/Latinx 181 95.3 
Marital status Married 153 80.6 
 Divorced 10 5.2 
 Widowed 8 4.2 
 Single 9 4.7 
 Partnered but not married 8 4.2 
 Other 2 1 
Current employment status Employed, full-time 94 49.5 
 Employed, part-time 28 14.7 
 Unemployed 32 16.8 
 Retired 13 6.8 
 Student 2 1.1 
 Other 21 11.1 
Employment status before COVID-19 Employed, full-time 104 54.7 
 Employed, part-time 30 15.8 
 Unemployed 19 10.0 
 Retired 12 6.3 
 Student 5 2.6 
 Other 20 10.5 
Highest level of education High school/GED 11 5.8 
 Technical school 4 2.1 
 Some college 36 18.9 
 Completed college 61 32.1 
 Graduate degree 78 41.1 
Annual household income Under $30,000 10 5.3 
 $30,001 - $50,000 11 5.8 
 $50,001 - $70,000 29 15.3 
 $70,001 - $100,000 32 16.8 
 $100,001 - $250,000 86 45.3 
 Above $250,000 18 9.5 







Descriptive Statistics  
Child Characteristics  
 The vast majority of respondents (84.7%) had only one child with an NDD. The average 
current age of caregivers’ children with NDD was 11.6 years. Approximately two thirds of these 
children were male (63.2%) and one third female (36.8%). See Tables 6 and 7. 
Table 6. Frequencies for questions related to affected child, family, and caregiving role  
[N = 190] 
 
Variable / Question Response N % 
Children with NDD 




















Child’s gender  







Affected family members  
(As far as you know, does your child have other 







Relationship to child 






Child of grandchild’s 














Length of caregiving relationship 
(How long have you been in the caregiving role for 
your child?) 
His/her whole life 
Most of his/her life 







Child’s living situation  
(Does your child live at home with you?) 
Yes, all of the time 





 No 4 2.1 
Care partner  
(Do you have a partner in providing care for your 
child?) 
Yes, all of the time 








* Value was assumed to be erroneous and was omitted from analyses 
Note: One respondent answered that they had “11” children with NDD. Based on their responses to other 
questions, it was assumed that this was a typographical error and that they intended to write “1”. Their 





Caregiving Roles, Family Structure, and Living Situation 
 The majority of caregivers reported that their child had no other family members known 
to have an NDD (70.0%). A total of 94.2% of respondents reported that they were the biological 
parent of the child in their care. The overwhelming majority of respondents had been in a 
caregiving role for their child’s entire life (96.3%), and shared a home with their child all of the 
time (95.8%). Most had a partner in caring for their child at least some of the time, with 71.1% 
of respondents reporting a full-time care partner and 16.3% reporting a part-time partner. See 
Table 6 above. 
Table 7. Descriptive statistics for all numerical variables 
 
Variable / Question N M SD Range 
Caregiver’s age (years) 
(What is your current age?) 
189 43.80 9.53 27 – 74 
Child’s age (years) 
(How old is your child currently?) 
182 11.65 7.74 1 – 42 
Child’s age at exome results (years) 
(How old was your child when you received 
results from exome testing?) 
184 8.35 7.51 0 – 42 
Child’s age at initial concerns (months) 
(How old was your child when you first had 
concerns about their behavior or 
development?) 
187 13.37 16.93 0 – 144 
Child’s age at clinical attention (years) 
(How old was your child when you sought 
out a behavioral or medical specialist about 
your concerns for your child’s development?) 
187 1.36 2.00 0 – 15 
Children with NDD  
(How many children do you have with some 
kind of NDD?) 
189 1.23 .87 0* – 4 
Children with ES for NDD 
(How many children do you have who had 
exome testing for an NDD?) 
189 1.13 .49 1 – 5* 
Time since ES 
(Child’s age – age at exome results) 
177 3.21 2.47 0 – 17 
Time since clinical attention 
(Child’s age – age at clinical attention)  
179 10.37 7.54 0 – 40 





Clinical Characteristics and Timeline 
The average child’s age at which caregivers sought specialist attention was 1.4 years, 
while the average child’s age at which ES was completed was 8.4 years. On average, at the time 
of completing the survey, 3.2 years had passed since receiving results from exome sequencing, 
and 10.4 years had passed since caregivers first sought clinical attention for their child (see 
Table 7). Mirroring the institution breakdown in recruitment, 86.8% of respondents’ children 
had ES testing ordered through Kennedy Krieger Institute and 13.2% through Johns Hopkins 
Medicine. The majority of respondents (83.7%) shared that they had already received some kind 
of diagnosis from a provider for their child’s neurodevelopmental differences (see Table 8). 
The most common NDD diagnosis or symptom was developmental delay (87.9%), 
followed by intellectual disability (62.1%) and autism spectrum disorder (45.3%). Out of the list 
of 19 skills provided, caregivers most frequently reported that their child needed help with 
participating in activities at school or in the community (74.7%), telling people what s/he wants 
(74.2%), and learning new things (71.6%) (see Tables 10 and 11).  
 Respondents were asked to indicate the result of their child’s ES. In total, 42.6% of 
respondents reported a positive/abnormal result, 31.1% reported a VUS/inconclusive result, 
22.1% reported a negative/normal result, and 4.2% were not sure. Exactly half of caregivers 
(50.0%) shared that they felt that they were still seeking an explanation for their child’s 
neurodevelopmental differences (see Table 8). 
 When further categorizing respondents into whether they had received diagnostic 
(positive) or non-diagnostic (VUS or negative) ES results, we were able to more clearly discern 
patterns in the data regarding the perceived explanatory power of ES. Among caregivers whose 




ES completely explained their child’s differences. None reported that the ES results did not 
explain their child’s NDD or only explained it a little. Among caregivers whose child received a 
non-diagnostic result, over half (57.4%) believed that the ES results did not explain their child’s 
neurodevelopmental differences, with 22.8% reporting “a little” and 14.8% reporting “partly”. In 
both groups, the majority of caregivers were not still seeking an explanation for their child’s 
differences, though this proportion was higher in the group of caregivers whose child had 
diagnostic ES results (76.5%) compared to children with non-diagnostic ES results (64.4%). See 
Table 9. 
Table 8. Frequencies for questions related to diagnosis and clinical genetics experience  
[N = 190] 
 
Variable / Question Response N % 
ES results  




Variant of uncertain 
significance (VUS) 
(inconclusive) 













ES results as explanation 
(How much do you feel the exome findings explain 
your child’s neurodevelopmental differences?) 















Seeking explanation  
(Do you feel that you are still searching for an 









(Where did you see the doctor who ordered your 
child’s genetic testing?)  
Kennedy Krieger Institute 





Reported NDD diagnosis  
(Has a provider given you a diagnosis for your 
child’s neurodevelopmental differences?) 
Yes 
No 








(From your perspective, how serious is your child’s 
condition compared to other people with an NDD?) 
Much less severe 
Somewhat less severe 
No more or less severe 
Somewhat more severe 

















Table 9. Frequencies for “ES results as explanation” and “seeking explanation” variables by 
diagnostic or non-diagnostic ES results [N = 182] 
 
Variable / Question Group Response N % 
ES results as explanation 
(How much do you feel 
the exome findings 




(N = 81) 
 
















(negative or VUS)  
(N = 101) 
















Do you feel that you are 
still searching for an 














(negative or VUS) 



























Question: Please check the boxes that describe problems that your child experiences. Check as 
many as apply to your child.  
 
Table 10. Descriptive statistics and frequencies for child’s symptoms/diagnoses [N = 190] 
 
 Frequency (N = 190) Count (N = 8) 
NDD Symptom/Diagnosis N % M  SD  Range 





1 – 7 Intellectual disability 118 62.1 
Autism / autism spectrum disorder 86 45.3 
Other neurological problem* 70 36.8 
Epilepsy / seizures 66 34.7 
Movement disorder 58 30.5 
Cerebral palsy 32 16.8 
Birth defects 13 6.8 
* For “other neurological problem,” a space was provided for respondents to elaborate. Answers included 
“ataxia,” “Floating Harbor Syndrome,” “cerebral artery occlusion,” “dystonia,” “abnormal ocular 


































Question: Please check the boxes below the describe tasks or skills that your child needs help 
with. Check as many apply to your child.  
 
Table 11. Descriptive statistics and frequencies for child’s difficulties [N = 190] 
 
 Frequency  
(N = 190) 
Count (N = 17) 
Task/Skill N % M  SD  Range 
Participating in activities at school or in 
the community 





0 – 17 
Telling people what s/he wants 141 74.2 
Learning new things 136 71.6 
Dressing or undressing self 115 60.5 
Behaving in an appropriate manner 113 59.5 
Toileting 110 57.9 
Participating in activities at home 109 57.4 
Understanding other people 103 54.2 
Regulating his/her mood 94 49.5 
Moving around at home, school, and/or 
community 
92 48.4 
Remembering things s/he knows 90 47.4 
Using his/her hands and arms to do the 
things s/he wants to do 
82 43.2 
Sleeping each night 81 42.6 
Performing functions such as 
feeding/eating 
73 38.4 
Getting along with children 59 31.1 
Getting along with adults 43 22.6 
Managing his/her pain 36 18.9 
Seeing 25 13.2 













Impact of COVID-19 
 The majority of respondents (63.9%) had been under a shelter-in-place or stay-at-home 
order at some point since the beginning of the COVID-19 pandemic in the United States in 
March 2020. However, over half (58.1%) stated that they were no longer under these restrictions 
at the time of their response to the survey. The majority of participants (58.6%) stated that they 
spent much more time caring for their child now than before COVID-19. Most participants 
experienced interruptions to their child’s therapies and services, with 49.7% reporting that all 
were disrupted and 35.6% reporting that some were disrupted. The greatest proportion of 
respondents (45.0%) shared that they did not experience financial difficulties as a result of the 
pandemic, with an additional 39.8% noting non-serious or minor financial strain. See Tables 12 













Table 12. Frequencies for questions related to impact of COVID-19 [N = 190] 
 
Variable / Question Response N % 
Shelter-in-place order 
(At any point since March, have you 
been living under a shelter-in-place 























(In thinking about the time before 
COVID-19 compared to now, how 
has your caregiving situation 
changed?) 
Much more time caring for my child 
A little more time caring for my child 
Same amount of time caring for my child 
A little less time caring for my child 












(Have you had any interruption of 
therapies or other services for your 
child due to COVID-19?) 
Yes, all interrupted 
Yes, some interrupted 










COVID financial difficulties 
(Have you had financial difficulties 
due to COVID-19?) 
Yes, serious 
Yes, some that I don’t consider serious 
Yes, minor  
No 
I don’t know yet 


















Table 13. Descriptive statistics for questions related to impact of COVID-19 [N = 190] 
 
Variable / Question N M SD Range 
Shelter-in-place duration (present) 
(For how many months have you been 
sheltering in place?) 
11 6.45 .82 5 – 8 
Shelter-in-place duration (past) 
(For how many months were you sheltering 
in place?) 













Factor Analyses: PAS, PUCHS, and COVID-19 Impact Questions 
Because the PAS and the PUCHS are relatively new validated scales that have each been 
utilized in fewer than five published studies, a factor analysis was conducted for each. A factor 
analysis was also run on the three novel questions created for this study concerning the impact of 
the COVID-19 pandemic on caregiving, child’s services, and finances. The factor analysis 
procedure described below was adapted from Field (2013) and from Laerd Statistics (2017c). 
Psychological Adaptation Scale (PAS) 
 To start, the factorability of the 20 PAS items was examined using several established 
criteria. All 20 items correlated with at least one other item at r ≥ .3, suggesting reasonable 
factorability (Laerd Statistics 2017c). The Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy was .935, which is considered “marvelous” according to Kaiser’s (1974) classification 
of measure values. Bartlett’s test of sphericity was significant (χ2(190) = 2812.14, p < .05). 
Lastly, the communalities were all above .3, helping to confirm that each item shared some 
common variance with other items. Given these overall indicators, we determined that factor 
analysis would be suitable for this scale. 
 Principal axis factoring (PAF) was run on the PAS per the suggestion of Field (2013), 
with extraction initially based on eigenvalues greater than 1. We utilized direct oblimin, an 
oblique rotation, in which factors are allowed to correlate. Small coefficients with an absolute 
value below .3 were suppressed to facilitate pattern discernment. PAF revealed three components 
with eigenvalues greater than 1, which explained a cumulative 66.8% of the total variance. 
Visual inspection of the scree plot suggested that retaining four components would be 
appropriate. This coheres with the four-factor model suggested by Biesecker and colleagues’ 




 The analysis was rerun, this time fixing extraction at four factors. The four-component 
solution explained 71.3% of the total variance, met the interpretability criterion, and displayed 
overall ‘simple structure’ (Laerd Statistics 2017). The interpretation of the data was consistent 
with the dimensions of adaptation that the PAS is designed to measure, with four coping efficacy 
items loading on Domain 1, four self-esteem items on Domain 2, four social integration items on 
Domain 3, and four spiritual wellbeing items on Domain 4. A table displaying factor loadings is 
provided in Appendix F. 
Parental Uncertainty About a Child’s Health Scale (PUCHS) 
 The factorability of the 15 weighted PUCHS items was examined using several 
established criteria. Weighted items were calculated by multiplying the unweighted item from 
Part A by its corresponding weight from Part B. All items correlated with at least one other item 
at r ≥ .3, suggesting reasonable factorability (Laerd Statistics 2017c). The KMO measure of 
sampling adequacy was .857, which is considered “meritorious” according to Kaiser’s (1974) 
classification of measure values. Bartlett’s test of sphericity was significant (χ2(105) = 1632.49,  
p < .05). All communalities were all above .3 except for item 4 (.035), helping to confirm that 
most items shared some common variance with other items. Given these overall indicators, we 
determined that factor analysis would be suitable for this scale. 
 Principal axis factoring (PAF) was run on the PUCHS fixing extraction at four factors. 
We selected this number of factors based on the four-factor models derived in the three previous 
studies that used the PUCHS (Macnamara 2014; Yanes et al. 2017; Bell et al. 2019). We utilized 
direct oblimin, an oblique rotation, in which factors are allowed to correlate. The four-
component solution explained 67.6% of the total variance, met the interpretability criterion, and 




 In our factor analysis, Domain 1 consisted of items 1, 2, 5, and 6; Domain 2 consisted of 
items 7, 8, 9, 10, and 11; Domain 3 consisted of items 3, 12, and 13; and Domain 4 consisted of 
items 14 and 15. A table displaying factor loadings is provided in Appendix F. Item 4 did not 
load on any of the four factors and thus was removed from the scale. The same item was 
excluded during model refinement by Umstead and colleagues (n.d.). In addition, item 3 
(“unsure of whether my child is expected to have a normal lifespan”) loaded on Domain 3, but its 
coefficient was relatively small (.32) and it conceptually diverged from the other two items in its 
domain. Due to this incongruity, item 3 was also removed from the scale, leaving a total of 13 
weighted items (26 total questions) loading on four domains. Scoring was adjusted to account for 
the exclusion of these two items. Domain labels were adopted from previous publications and 
modified to reflect the items that loaded on them. The final four subscales were Medical 
Management (four weighted items), Family/Reproductive (five weighted items), Social (two 
weighted items), and Existential (two weighted items).  
COVID-19 Impact Questions 
 To determine whether the three COVID-19 questions hung together and could be reduced 
to a single score or component, the same procedure was run as that described for the PAS and 
PUCHS above. The applied factorability criteria suggested poor factorability for these items. 
Correlation coefficients fell well below the established threshold of r ≥ .3. The KMO measure of 
sampling adequacy was .554, which is considered “miserable” according to Kaiser’s (1974) 
classification of measure values. Finally, the one component with an eigenvalue greater than 1 
explained only 42.5% of the total variance. Given these indicators, no further factor analysis was 





Summary Statistics for Key Dependent and Independent Variables 
Means, standard deviations, medians, and ranges for each scale and subscale are 
presented in Table 14. The following data in parentheses are presented as mean ± standard 
deviation. Most participants endorsed beliefs about the chronic nature of their child’s condition 
(chronicity: 26.93 ± 3.54) and perceived it as having a significant impact (consequences: 23.66 ± 
4.34). Participants felt that they had a moderate degree of personal control over their child’s 
condition (personal control: 19.92 ± 5.02), but fairly low treatment control (treatment control: 
14.30 ± 4.00). Participants reported that they found it moderately difficult to make sense of their 
child’s condition (coherence: 16.88 ± 4.98). In general, participants did not strongly believe that 
their child’s condition followed a cyclical pattern (cyclicity: 10.40 ± 4.19). Participants felt that 
their child’s NDD modestly affected them emotionally (emotional representation: 19.72 ± 4.59). 
Participants held a moderately strong agreement that genetics was a cause for their 
child’s NDD (genetics/heredity causal attribution: 4.03 ± 1.16). When asked to “list in rank-order 
the three most important factors you now believe caused your child’s condition,” the majority of 
participants who responded (62.6%) indicated “genetics” or some variant thereof as the most 
important factor in causing their child’s NDD. Other causal factors ranked first included God’s 
will (8.4%), chance or luck (5.6%), and pregnancy complication or concern (3.9%).  
Participants’ weighted uncertainty was moderately low (PUCHS: 1.59 ± .88). Within 
dimensions of uncertainty, uncertainty related to medical management for their child’s NDD 
(1.61 ± .98), to family and reproductive issues (1.62 ± 1.05), and to social support (2.03 ± 1.33) 
was also moderately low. Respondents indicated low levels of uncertainty related to the meaning 




Overall, participants in this study were moderately well-adapted to their child’s 
neurodevelopmental disorder (PAS: 3.75 ± 0.74). Specifically, participants showed moderately 
high levels of coping efficacy (3.89 ± 0.88), self-esteem (3.88 ± 0.83), and social integration 
(3.84 ± 0.88). Participants indicated moderate levels of spiritual wellbeing (3.39 ± 1.01). 
Respondents’ levels of depression, anxiety, and stress were low on the whole (DASS-21: 7.39 ± 





















Table 14. Summary statistics for key independent and dependent scale variables [N = 190] 
 
 
Variable (Scale),  
















Total weighted uncertainty 
(PUCHS), 13 weighted items 
1.59 1.51 .88 0 – 4 0 – 4 
Medical management uncertainty 
(PUCHS), 4 weighted items 
1.61 1.54 .98 0 – 4 0 – 4 
Family/reproductive uncertainty 
(PUCHS), 5 weighted items 
1.52 1.30 1.05 0 – 4 0 – 4 
Social uncertainty (PUCHS),  
2 weighted items 
2.03 2.00 1.33 0 – 4 0 – 4 
Existential uncertainty (PUCHS),  
2 weighted items 
1.00 1.00 1.12 0 – 4 0 – 4 
Chronicity (IPQ-RA), 6 items 26.93 28.00 3.48 12 – 30 6 – 30 
 
Consequences (IPQ-RA), 6 items 23.58 24.00 4.34 11 – 30 6 – 30 
 
Personal control (IPQ-RA),  
5 items 
19.92 21.00 5.02 6 – 30 5 – 25 
 
Treatment control (IPQ-RA),  
5 items 
14.30 15.00 4.00 5 – 25 5 – 25 
Coherence (IPQ-RA), 5 items 16.75 17.00 4.98 5 – 25 5 – 25 
 
Cyclicity (IPQ-RA), 4 items 
 
10.40 10.00 4.19 4 – 20 4 – 20 
Emotional representation  
(IPQ-RA), 6 items 
19.72 20.00 4.59 6 – 30 6 – 30 
Genetic causal attribution  
(IPQ-RA), 1 item 
4.03 4.00 1.16 
 
1 – 5 1 – 5 
Psychological adaptation (PAS),  
20 items  
3.75 3.80 0.74 1 – 5 1 – 5 
Coping efficacy (PAS), 5 items 
 
3.89 4.00 0.79 1 – 5 1 – 5 
Self-esteem (PAS), 5 items 
 
3.88 4.00 0.83 1 – 5 1 – 5 
Social integration (PAS),  
5 items 
3.84 4.00 0.77 1 – 5 1 – 5 
Spiritual wellbeing (PAS),  
5 items 
3.39 3.40 1.01 1 – 5 1 – 5 
Depression (DASS-21), 7 items 
 
7.39 4.00 9.21 0 – 38 0 – 42 
Anxiety (DASS-21), 7 items 4.49 2.00 6.37 0 – 34 0 – 42 
 
Stress (DASS-21), 7 items 
 






Internal Reliability of Scales 
 All scales demonstrated good to excellent internal reliability as determined by a > 0.70 
(Cronbach 1951). The IPQ-RA had an a = 0.72, the PUCHS (13 weighted items) had an a = 
0.90, the PAS had an a = 0.95, and the DASS-21 had an a = 0.94. For the PUCHS subscales, 
Medical Management had an a = 0.79, Family/Reproductive had an a = 0.86, Social had an a = 
0.94, and Existential had an a = 0.91.  
Test for Display Order Effects 
 The display order of the PAS and PUCHS in the survey was randomized for respondents. 
Independent samples t-tests were conducted for the total PAS score, total PUCHS score, and for 
the 26 individual questions on the PUCHS to investigate the presence of order effects. Two 
questions on the PUCHS (2a and 13b) were found to differ significantly (p ≤ .05) based on 
viewing the PAS or the PUCHS first. However, there was no significant difference in overall raw 
PAS or PUCHS scores between the two display order groups. Because there were individual 
items that varied significantly on the basis of display order, display order was included in logistic 











Table 15. T-test for order effects of PAS display order [N = 190] 
 
 Order PAS Displayed  




 1st, PUCHS 2nd  
(N = 92) 
2nd, PUCHS 1st  
(N = 98) 
  
 M SD M SD t p 
PUCHS Q2a* 2.09 1.24 1.65 1.24 .08, .79 2.41 .02 
PUCHS Q13b* 3.84 1.16 4.15 1.01 -.63, -.01 -2.01 .05 
PUCHS Total  
(13 weighted) 
1.70 .80 1.49 .94 -.06, .45 1.54 .13 
PAS Mean 3.80 .71 3.71 .76 -.13, .29 .72 .44 
Note: Bolded values represent statistically significant differences at p ≤ .05.  
* Range of scores for questions on Part A of the PUCHS is 0 to 4. Range of scores for questions on Part B 





















A Priori Hypothesis Testing 
For the purposes of the following analyses, participants who responded “I don’t know” to 
the question about ES results (N = 8) were excluded, leaving a sample size of N = 182. Prior to 
construction of full logistic regression models, univariate analyses were run between all 
key/predictor (independent) variables and the outcome (dependent) variable of interest to 
determine which predictors would be included in the corresponding models. Relationships 




















Table 16. Betas and p-values for univariate logistic regressions of dichotomized outcome 










Control variables     
Children with NDD -.44 (.14) .43 (.11) .53 (.07) -.02 (.93) 
Child’s age .01 (.77) .01 (.76) .01 (.66) .00 (.83) 
Caregiver’s age -.02 (.28) .01 (.53) .00 (.85) .01 (.42) 
Caregiver’s education -.16 (.24) -.08 (.56) -.03 (.88) .13 (.34) 
Caregiver’s income -.03 (.81) -.19 (.13) .05 (.71) -.03 (.78) 
Caregiver’s gender .02 (.96) -.02 (.97) .24 (.69) .01 (.99) 
PAS/PUCHS display order .10 (.73) -1.39 (<.01) -.49 (.16) -.49 (.11) 
COVID caregiving .08 (.56) .04 (.80) -.21 (.20) .10 (.50) 
COVID therapies -.24 (.30) .36 (.18) .13 (.65) .55 (.03) 
COVID financial -.14 (.35) .42 (<.01) .18 (.29) .45 (<.01) 
Child symptoms/diagnoses -.10 (.35) .18 (.14) .20 (.13) .12 (.30) 
Child difficulties -.02 (.53) .09 (.02) .10 (.03) .11 (<.01) 
Perceived seriousness .00 (.98) .04 (.03) .30 (.06) .28 (.04) 
Explanatory power -.06 (.55) -.23 (.04) -.26 (.03) -.15 (.13) 
Key variables     
Chronicity  -.03 (.48) .07 (.20) .19 (.01) .05 (.27) 
Consequences -.04 (.19) .09 (.02) .12 (.01) .12 (<.01) 
Personal control .05 (.10) -.09 (<.01) -.06 (.09) -.03 (.28) 
Treatment control .05 (.17) -.04 (.28) -.04 (.32) -.02 (.58) 
Coherence .02 (.46) -.02 (.60) -.07 (.04) -.05 (.14) 
Cyclicity .01 (.80) .02 (.59) .02 (.57) .04 (.31) 
Emotional representation  -.08 (.01) .19 (<.01) .19 (<.01) .22 (<.01) 
Genetic causal attribution -.10 (.44) -.05 (.71) -.07 (.62) -.15 (.23) 
Time since ES  .02 (.69) -.01 (.87) -.04 (.61) .04 (.58) 
Time since clinical attention .00 (.85) .00 (.99) .01 (.85) .01 (.75) 
ES results: VUS vs. positive  -.04 (.88) -.56 (.10) -.54 (.14) -.28 (.36) 
ES results: VUS vs. neg -.40 (.21) .15 (.67) .25 (.50) .46 (.15) 
Uncertainty (total) -.16 (.35) .60 (<.01) .56 (<.01) .51 (<.01) 
   Medical management -.12 (.44)  
   Family/reproductive .03 (.85) 
   Social -.18 (.16) 
   Existential  -.25 (.06) 
Note: Outcome variables were dichotomized in the following ways: Adaptation: split at the mean (3.75); 
Depression, Anxiety, Stress: split at value delineating “normal” from “abnormal” per DASS-21 scoring 
guide (Lovibond & Lovibond 1995), cut-points are 9, 7, and 14, respectively 
† Relationships that are statistically significant at p ≤ .30 are bolded in the corresponding cell of the table. 
Note that all control variables (“children with NDD” through “explanatory power”) were included in 







Aim 1: Influence of ES Results Category on NDD Appraisals 
Hypothesis 1.1.  
A series of one-way ANOVA were conducted to determine if illness appraisals (scores on 
each IPQ-RA subscale, genetic causal attribution, and uncertainty via the PUCHS) were different 
for caregivers whose children received different types of ES results. Two of the eight analyzed 
illness representation dimensions, as well as uncertainty, revealed significant differences 
between groups with different kinds of test results. The one-way ANOVA analyses are 
summarized in Table 17(a), with results of post-hoc contrasts for the three statistically 
significant ANOVA summarized in Table 17(b). 
Treatment control perceptions differed between categories of ES results, F(2,180) = 3.90, 
p < .05. Treatment control score increased from the positive ES (13.36 ± 3.82), to VUS (14.86 ± 
3.90), to negative ES (15.02 ± 3.84) results groups, in that order, indicating that caregivers who 
reported negative ES results held the strongest beliefs about the controllability of their child’s 
NDD through treatment. Tukey-Kramer post-hoc analysis revealed that a statistically significant 
difference between the positive and negative results groups (1.66, 95% CI (0.10 to 3.21), p < 
.05), but no other group differences were statistically significant. 
Coherence was statistically significantly different between categories of ES results, 
F(2,180) = 10.14, p < .01. Coherence score increased from the VUS (15.21 ± 5.18), to negative 
ES (15.75 ± 5.07), to positive ES (18.65 ± 4.14) results groups, in that order, indicating that 
caregivers who reported positive ES results felt most strongly that their child’s NDD made sense. 
Games-Howell (for unequal variances) post-hoc analysis revealed a statistically significant 




as well as a statistically significant difference between the negative and positive groups (2.90, 
95% CI (.99 to 4.81), p < .01).  
Weighted uncertainty as measured by the PUCHS was statistically significantly different 
across the categories of ES results, F(2,180) = 8.32, p < .01. Uncertainty score increased from 
the positive (1.32 ± .85), to negative (1.76 ± .85), to VUS (1.92 ± .87) ES results groups, in that 
order, indicating that caregivers who reported a VUS result had the highest levels of uncertainty. 
Tukey-Kramer post-hoc analysis revealed a statistically significant difference between the VUS 
and positive ES results groups (.60, 95% CI (.22 to .99), p < .01), and a statistically significant 
difference between the negative and positive ES results groups (.44, 95% CI (.09 to .79), p = 
.01).  
No significant intergroup differences were found for the chronicity, consequences, 















Table 17(a): One-way ANOVA of illness representations and uncertainty by ES results group  
[N = 182] 
 





 Positive  
(N = 81) 
Negative 
(N = 59) 
VUS 
(N = 42) 
 
 M SD M SD M SD p 
Chronicity 
 
27.51 3.28 26.86 2.86 26.63 3.40 1.30 .28 
Consequences  23.59 
 
4.02 23.53 4.74 23.14 4.42 .16 .85 
Personal 
control 
19.36 5.34 20.15 4.54 20.42 4.97 .78 .46 
Treatment 
control 
13.36 3.82 15.02 3.84 14.86 3.90 3.90 .02 
Coherence 
 
18.65 4.14 15.75 5.07 15.21 5.18 10.14 < .01 
Cyclicity 
 
9.75 4.07 11.44 4.32 10.60 3.91 2.89 .06 
Emotional 
representation 
19.42 4.89 19.95 4.29 19.64 4.58 .32 .73 
Genetic causal 
attribution 
4.15 1.26 4.00 1.10 3.95 .98 .51 .60 
Uncertainty 1.32 .85 1.76 .85 1.92 .87 8.32 < .01 
Note: Bolded values represent statistically significant contrasts at p < .05.  
 
Table 17(b): Tukey-Kramer and Games-Howell post-hoc tests for pairwise comparisons of 




























VUS vs. positive 1.50 .10 -.21 3.22 
VUS vs. negative .16 .98 -1.66 .20 
Positive vs. negative 1.66 .03 .10 3.21 
Coherence 
(Games-Howell) 
VUS vs. positive 3.44 <.01 1.25 5.63 
VUS vs. negative .54 .86 -1.92 2.99 
Positive vs. negative 2.90 <.01 .99 4.81 
Uncertainty 
(Tukey-Kramer) 
VUS vs. positive .60 <.01 .22 .99 
VUS vs. negative .16 .62 -.25 .57 
Positive vs. negative .44 .01 .09 .79 







 To test the moderating effects of uncertainty, a median split was applied to the weighted 
uncertainty variable (PUCHS score) with a cut-point at 1.51. This cut-point was generated by 
running the visual binning operation in SPSS and dividing the data into two equal centiles, as no 
guidance is provided in the literature on how to convert the PUCHS score to a dichotomous 
categorical variable. Any values up to and including 1.51 were categorized as 1 = “low 
uncertainty,” and values above 1.51 were categorized as 2 = “high uncertainty.” Any significant 
interactions between the dichotomous uncertainty variable and ES results type would indicate 
moderation.  
A series of two-way ANOVA were conducted to examine the effects of ES results 
category and uncertainty level on illness representations. Residual analysis was performed to test 
for the assumptions of the two-way ANOVA. Outliers were assessed by inspection of a box-plot 
and homogeneity of variances was assessed by Levene’s test. There were no outliers, and the 
assumption of homogeneity of variances was violated, as assessed by Levene’s test for equality 
of variances, p = .005 for coherence.  
None of the interaction effects between ES results category and uncertainty on illness 
representation dimensions were statistically significant (see Table 18). For treatment control and 
coherence, statistically significant main effects were found for ES results, mirroring the findings 
discussed above under Hypothesis 1.1. There were significant main effects found for uncertainty 
on personal control, F(1,177) = 4.57, p < .05, on coherence, F(1,177) = 12.76, p < .01, and on 
emotional representation, F(1,177) = 4.07, p = .05. Greater perceived uncertainty was associated 
with lower perceived personal control, lower perceived coherence, and greater degree of negative 




Table 18. Main effects and interactions from 2 x 3 two-way ANOVA of illness representations 




















Chronicity Uncertainty 1 .00 .99 Passed 
(p = .51) ES Results 2 1.03 .36 
Interaction 
Corrected model 
2 .67 .51 
5 .80 .55 
Consequences Uncertainty 1 .00 .97 Passed 
ES Results 2 .17 .87 (p = .13) 
Interaction 2 1.93 .17  
Corrected model 5 .88 .50  
Personal control Uncertainty 1 4.57 .03 Passed  
ES Results 2 1.51 .22 (p = .06) 
Interaction 2 .55 .58  
Corrected model 5 1.43 .21  
Treatment control Uncertainty 1 .62 .43 Passed 
ES Results 2 3.96 .02 (p = .78) 
Interaction 2 .70 .50  
Corrected model 5 1.94 .09  
Coherence Uncertainty 1 12.76 <.01 Violated 
ES Results 2 5.19 <.01 (p = .01) 
Interaction 2 2.83 .06  
Corrected model 5 8.14 <.01  
Cyclicity Uncertainty 1 1.41 .24 Passed 
ES Results 2 1.75 .18 (p = .30) 
Interaction 2 .17 .84  
Corrected model 5 1.60 .16  
Emotional 
representation 
Uncertainty 1 4.07 .05 Passed 
ES Results 2 .03 .97 (p = .81) 
Interaction 2 1.24 .29  
















(p = .03) 
Corrected model 5 .83 .53  









Aim 2: NDD Appraisals as Predictors of Adaptation and Affective Outcomes 
Hypothesis 2.1.  
 Univariate linear regressions were conducted between each predictor variable and the 
outcome variables (psychological adaptation, depression, anxiety, and stress). However, residual 
plots indicated a lack of linearity between all pairs of variables, violating an integral assumption 
of linear regression analysis (for scatterplot visualizations, see Appendix G). As such, binomial 
logistic regression analyses were conducted to assess the ability of the independent variables to 
predict high or low levels of the four outcomes.  
 To dichotomize psychological adaptation, a mean split was conducted wherein values up 
to and including the mean from the PAS (3.75) were categorized as 0/“low” and values greater 
than 3.75 were categorized as 1/“high”. For the affective outcome variables, cut-points for 
dichotomization were established by the DASS-21 scoring guide (Lovibond & Lovibond 1995). 
Depression scores greater than 9, Anxiety scores greater than 7, and Stress scores greater than 14 
were considered beyond the “normal” range. See Appendix B for a summary of the variable 
dichotomization scheme.  
To determine which key variables would be included in each logistic regression model, a 
series of univariate logistic regression analyses were first conducted regressing each of the four 
dichotomous outcome variables. Any relationships that displayed significance at p ≤ .30 were 
included in the corresponding hierarchical logistic regression models (refer to Table 19).  
Psychological adaptation. A hierarchical binomial logistic regression was performed to 
ascertain the effects of four illness representation dimensions (consequences, personal control, 
treatment control, and emotional representation), the VUS-versus-negative ES results 




participants are better adapted to their child’s NDD (N = 96). Linearity of the continuous 
variables with respect to the logit (log odds transformation) of the dependent variable was 
assessed via the Box-Tidwell (1962) procedure. As part of this procedure, all continuous 
predictor variables were transformed into their natural logs (ln(variable)). Then, interaction terms 
between the predictor variable and its natural log were created (variable * ln(variable)) and 
entered into the regression model along with the untransformed predictor variables. Per the Box-
Tidwell guidance, if these interaction terms fail to reach statistical significance, then the 
assumption of linearity is upheld (Laerd Statistics 2017b).  
In addition, a Bonferroni correction was applied using all 21 terms in the model, resulting 
in statistical significance for the linearity assumption testing being accepted when p ≤ .002 , 
obtained by dividing the significance threshold of p = .05 by 21 (Tabachnick & Fidell 2014; 
Laerd Statistics 2017b). Based on this assessment, all continuous independent variables were 
found to be linearly related to the logit of the dependent variable based on p values greater than 
.002. Importantly, this adjusted significance level of p ≤ .002 from the Bonferroni correction was 
used to determine the statistical significance of individual coefficients in the logistic regression 
model. Applying Bonferroni correction to regression analysis is advised by numerous 
statisticians to protect against possible inflation of type I error and bias from repeated testing 
effects (e.g., Mundfrom et al. 2006; Taylor 2011).  
The 14 control variables were entered into the regression model in Step 1, followed by 
the seven key predictor variables in Step 2. The final logistic regression model reached statistical 
significance, χ2(22) = 36.31, p = .028. The model correctly classified 72.7% of cases. Sensitivity 




value was 69.6%.(see Table 19). The overall fit of the model improved by 15.0% (Nagelkerke 
R2 9.4% to 24.4%) from Step 1 to Step 2 by adding the set of eight predictor variables.  
Of the 22 independent variables, none reached statistical significance based on the 
Bonferroni adjusted p value of .002. However, three of the variables (personal control, emotional 
representation, and VUS-vs.-negative ES results comparison) displayed trends (see Table 19). 
Caregivers whose child had a VUS ES result had 2.74 times higher odds to report better overall 
adaptation than caregivers whose child had a negative ES result, when holding other covariates 
at a fixed value. While holding other covariates at a constant value, increasing perception of 
personal control over the child’s NDD by one point was associated with 14% higher likelihood 
of being in the group with above-average adaptation. In addition, a one-point increase in negative 
emotion representation of the child’s NDD was associated with an 11% reduction in the 
likelihood of being in the group with above-average adaptation.  
The area under the ROC curve for the regression with adaptation as the dependent 
variable was .77 (95% CI, .68 to .83), which is an indicator that the model provides an acceptable 
level of discrimination according to Hosmer et al. (2013). See Appendix H for corresponding 











Table 19. Binomial logistic regression of psychological adaptation on independent variables  
[N = 182] 
 
Step and variable 
Dependent: Adaptation 
B SE Wald χ2 p Odds 
Ratio 
95% CI for 
Odds Ratio 
     (eB) Lower Upper 
(1) Control variables 
Children with NDD 
Child’s age 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 















































































































(2) Control + Key variables 
Children with NDD 
Child’s age 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 















































































































































































Note: Cox & Snell R2 = .18. Nagelkerke R2 = .24. Hosmer & Lemeshow goodness-of-fit test: χ2(8) = 4.86,  
p = .77.  
Bolded values signify coefficients with p ≤ .05 considered to be trends in the data, which are discussed in more 




Depression. A hierarchical binomial logistic regression was performed to ascertain the 
effects of five illness representation dimensions (chronicity, consequences, personal control, 
treatment control, and emotional representation), the VUS-versus-positive ES results 
comparison, and total weighted uncertainty on the likelihood that participants have mild to 
severe signs of depression (N = 52). Linearity of the continuous variables with respect to the 
logit (log odds transformation) of the dependent variable was assessed via the Box-Tidwell 
(1962) procedure. Please refer to the preceding section (“Adaptation”) for a description of this 
procedure and its parameters. 
As with the logistic regression with adaptation as the dependent variable, a Bonferroni 
correction was applied using all 22 terms in the model, resulting in statistical significance for the 
linearity assumption testing being accepted when p ≤ .002 , obtained by dividing the significance 
threshold of p = .05 by 22 (Tabachnick & Fidell 2014; Laerd Statistics 2017b). Based on this 
assessment, all continuous independent variables were found to be linearly related to the logit of 
the dependent variable based on p values greater than .002. As before, this adjusted significance 
level of p ≤ .002 from the Bonferroni correction was used to determine the statistical significance 
of individual coefficients in the logistic regression model.  
The 14 control variables were entered into the regression model in Step 1, followed by 
the seven key predictor variables in Step 2. The final logistic regression model reached statistical 
significance, χ2(21) = 58.19, p < .01. The model correctly classified 81.3% of cases. Sensitivity 
was 57.5%, specificity was 90.4%, positive predictive value was 69.7%, and negative predictive 
value was 84.7%. Of the 21 independent variables, two emerged as statistically significant: 




the model improved by 17.8% variance explained (Nagelkerke R2 31.4% to 49.2%) from Step 1 
to Step 2 by adding the set of seven predictor variables. 
The PAS/PUCHS display order variable was included in the model as a control, but 
proved statistically significant even once the key variables had been entered. Participants who 
viewed the PUCHS first and the PAS second (directly before the DASS-21 affective measures) 
had an 83% lower likelihood of being in the group reporting mild to high depressive symptoms 
than participants who viewed the PAS second, suggesting a substantial recency or framing effect. 
Furthermore, holding other covariates at a constant value, a one-point increase on the emotional 
representation scale was associated with a 39% increase in the odds of being in the mild to high 
depressive symptoms group.  
The area under the ROC curve for the regression with depression as the dependent 
variable was .87 (95% CI, .81 to .93), which is an indicator that the model provides an excellent 
level of discrimination according to Hosmer et al. (2013). See Appendix G for corresponding 













Table 20. Binomial logistic regression of depression on independent variables [N = 182] 
 
Step and variable 
Dependent: Depression 
B SE Wald χ2 p Odds 
Ratio 
95% CI for Odds 
Ratio 
     (eB) Lower Upper 
(1) Control variables 
Children with NDD 
Child’s age 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 










































































































-2.57 1.99 1.71 .19 .08 
(2) Control + Key variables 
Children with NDD 
Child’s age 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 











ES results: VUS vs. pos 
Uncertainty 
Constant 

































































































































































Note: Cox & Snell R2 = .34. Nagelkerke R2 = .49. Hosmer & Lemeshow goodness-of-fit test: χ2(8) = 7.22,  
p = .51.  





Anxiety. A hierarchical binomial logistic regression was performed to ascertain the 
effects of five illness representation dimensions (chronicity, consequences, personal control, 
coherence, and emotional representation), the VUS-versus-positive ES results comparison, and 
total weighted uncertainty on the likelihood that participants have mild to severe signs of anxiety 
(N = 41). Linearity of the continuous variables with respect to the logit (log odds transformation) 
of the dependent variable was assessed via the Box-Tidwell (1962) procedure. Please refer to the 
Adaptation section for a description of this procedure and its parameters. 
As with the logistic regressions on adaptation and depression, a Bonferroni correction 
was applied using all 21 terms in the model, resulting in statistical significance for the linearity 
assumption testing being accepted when p ≤ .002, obtained by dividing the significance threshold 
of p = .05 by 22 (Tabachnick & Fidell 2014; Laerd Statistics 2017b). Based on this assessment, 
all continuous independent variables were found to be linearly related to the logit of the 
dependent variable based on p values greater than .002. As before, this adjusted significance 
level of p ≤ .002 from the Bonferroni correction was used to determine the statistical significance 
of individual coefficients in the logistic regression model.  
The 14 control variables were entered into the regression model in Step 1, followed by 
the seven key predictor variables in Step 2. The final logistic regression model reached statistical 
significance, χ2(21) = 49.20, p < .01. The model correctly classified 85.4% of cases. Sensitivity 
was 51.7%, specificity was 93.9%, positive predictive value was 68.2%, and negative predictive 
value was 88.5%. The overall predictive power of the model improved by 12.8% (Nagelkerke R2 
33.6% to 46.4%) from Step 1 to Step 2 by adding the set of seven predictor variables.  
Of the 21 independent variables, none reached statistical significance based on the 




income and change to caregiving activities during COVID) and one of the key variables 
(emotional representation) displayed trends (see Table 21). While holding other covariates at a 
constant value, increasing annual income by one unit (moving from one income range to the next 
highest) was associated with an 83% higher likelihood of being in the group reporting anxiety 
symptoms beyond the normal range. Additionally, moving from one caregiving category to the 
next (indicating decreasing time spent caring for one’s child during COVID) was associated with 
55% lower likelihood of being in the higher anxiety group. Finally, a one-point increase on the 
emotional representation scale was associated with a 27% increase in the odds of being in the 
mild to high anxiety group. 
The area under the ROC curve for the regression with anxiety as the dependent variable 
was .88 (95% CI, .81 to .95), which is an indicator that the model provides an excellent level of 















Table 21. Binomial logistic regression of anxiety on independent variables [N = 182] 
 
Step and variable 
Dependent: Anxiety 
B SE Wald χ2 p Odds 
Ratio 
95% CI for Odds 
Ratio 
     (eB) Lower Upper 
(1) Control variables 
Children with NDD 
Child’s age 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 











































































































(2) Control + Key variables 
Children with NDD 
Child’s age 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 











ES results: VUS vs. pos 
Uncertainty  
Constant 





























































































































































Note: Cox & Snell R2 = .30. Nagelkerke R2 = .46. Hosmer & Lemeshow goodness-of-fit test: χ2(8) = 8.03,  
p = .43. 





Stress. A hierarchical binomial logistic regression was performed to ascertain the effects 
of five illness representation dimensions (consequences, personal control, coherence, emotional 
representation, and genetic causal attribution), the VUS-versus-positive ES results comparison, 
and total weighted uncertainty on the likelihood that participants have mild to severe signs of 
anxiety (N = 70). Linearity of the continuous variables with respect to the logit (log odds 
transformation) of the dependent variable was assessed via the Box-Tidwell (1962) procedure. 
Please refer to the Adaptation section for a description of this procedure and its parameters. 
As with the logistic regressions on adaptation, depression, and anxiety, a Bonferroni 
correction was applied using all 21 terms in the model, resulting in statistical significance for the 
linearity assumption testing being accepted when p ≤ .002, obtained by dividing the significance 
threshold of p = .05 by 22 (Tabachnick & Fidell 2014; Laerd Statistics 2017b). Based on this 
assessment, all continuous independent variables were found to be linearly related to the logit of 
the dependent variable based on p values greater than .002. As before, this adjusted significance 
level of p ≤ .002 from the Bonferroni correction was used to determine the statistical significance 
of individual coefficients in the logistic regression model.  
The 14 control variables were entered into the regression model in Step 1, followed by 
the seven key predictor variables in Step 2. The final logistic regression model reached statistical 
significance, χ2(21) = 43.60, p < .01. The model correctly classified 79.2% of cases. Sensitivity 
was 61.5%, specificity was 89.1%, positive predictive value was 76.2%, and negative predictive 
value was 67.2%. The overall predictive power of the model improved by 16.9% (Nagelkerke R2 
19.7% to 36.6%) from Step 1 to Step 2 by adding the set of seven predictor variables.  
Of the 21 independent variables, none reached statistical significance based on the 




emotional representation (see Table 22). A one-point increase on the emotional representation 
scale, while holding other covariates at a constant value, was associated with a 22% increase in 
the odds of being in the group reporting signs of stress beyond the normal range.  
The area under the ROC curve for the regression with stress as the dependent variable 
was .81 (95% CI, .74 to .89), which is an indicator that the model provides an excellent level of 





















Table 22. Binomial logistic regression of stress on independent variables [N = 182] 
 
Step and variable 
Dependent: Stress 
B SE Wald χ2 p Odds 
Ratio 
95% CI for Odds 
Ratio 
     (eB) Lower Upper 
(1) Control variables 
Children with NDD 
Child’s age 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 











































































































(2) Control + Key variables 
Children with NDD 
Child’s age 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 










Genetic causal attribution 
ES results: VUS vs. pos 
Uncertainty  
Constant 





























































































































































Note: Cox & Snell R2 = .27. Nagelkerke R2 = .37. Hosmer & Lemeshow goodness-of-fit test: χ2(8) = 8.33,  
p = .40. 





Aim 3: Time in Relation to NDD Appraisals, Adaptation, and Affective Outcomes 
Hypothesis 3.1 
 Univariate logistic regression analyses were conducted between each of the two time 
variables (Time Since Exome Sequencing (ES) and Time Since Clinical Attention (CA)) and 
each of the four outcome variables (adaptation, depression, anxiety, and stress). For Time Since 
ES, the range was 0 to 17 years, with a mean of 3.2 years. For Time Since CA, the range was 0 
to 40 years, with a mean of 10.5 years. The distributions of both time variables were strongly 
positively skewed, with a relatively high proportion of respondents’ children having undergone 
ES and received clinical attention more recently (see Figure 2). None of these relationships were 
statistically significant (see Table 16 in the preceding section).  
 Each logistic regression model from Aim 2 was completed two additional times, adding 
one of the two time variables in each as part of Step 2. The Nagelkerke R2, correct classification 
percentage, and chi-square values were compared between the models without and with each 
time variable to determine if the addition of time improved the model, and if the time variable 
emerged as a significant predictor of the outcome variable (see Table 23).   
In the regression with adaptation as the dependent variable, adding the Time Since ES 
variable to the model improved the classification accuracy, but marginally lowered the 
Nagelkerke R2. In the regression with depression as the dependent variable, adding the Time 
Since ES variable to the model slightly improved classification accuracy and variance in 
depression explained by the model. This same pattern was observed in the regressions on anxiety 
and stress.  
In the regression with adaptation as the dependent variable, adding the Time Since CA 




classification accuracy. In the regression with depression as the dependent variable, adding Time 
Since CA did not alter the Nagelkerke R2 of the model and marginally improved classification 
accuracy. In the regressions with anxiety and stress as the dependent variables, the addition of 
Time Since CA to each model slightly improved both Nagelkerke R2 and classification accuracy.  
In all four of the previously listed models, neither Time Since ES nor Time Since CA was 
a statistically significant predictor of the outcome. Thus, the hypothesis that greater temporal 
distance since testing or clinical attention predicts better adaptation was not supported.  
Hypothesis 3.2 
 Because neither time variable was found to be a significant predictor of outcomes, no 

















Table 23. Comparison of logistic regression models with and without inclusion of time variables 
[N = 182] 
 
 B p Nagelkerke 
R2 
% correct χ2 (p) 
Adaptation w/o Time Since ES -- -- .22 60.7 27.39 (.10) 
w/ Time Since ES .08 .29 .22 71.4 26.38 (.15) 
Depression w/o Time Since ES -- -- .48 81.3 58.19 (<.01) 
w/ Time Since ES -.06 .62 .49 83.0 58.39 (<.01) 
Anxiety  w/o Time Since ES -- -- .46 85.4 49.20 (<.01) 
w/ Time Since ES .11 .40 .46 86.5 49.31 (<.01) 
Stress  w/o Time Since ES -- -- .36 79.2 43.60 (<.01) 
w/ Time Since ES .12 .25 .37 79.4 44.62 (<.01) 
 
Adaptation w/o Time Since CA -- -- .22 70.7 27.39 (.10) 
w/ Time Since CA -.16 .24 .23 69.6 27.76 (.12) 
Depression w/o Time Since CA -- -- .48 81.3 58.19 (<.01) 
w/ Time Since CA -.08 .57 .48 82.5 57.93 (<.01) 
Anxiety  w/o Time Since CA -- -- .46 85.4 49.20 (<.01) 
w/ Time Since CA .13 .36 .47 86.0 49.69 (<.01) 
Stress  w/o Time Since CA -- -- .36 79.2 43.60 (<.01) 

















Figure 2. Histograms of self-reported number of years since ES (above) and years since CA 









































Supplemental Aims: Predictors of Uncertainty 
In addition to the additional aims of the study, we subsequently proposed to address two 
new specific aims: 1) to investigate how various dimensions of caregivers’ NDD-associated 
uncertainty relate to types of results from ES, and 2) to assess predictors of total 
uncertainty, including illness representations. For Supplemental Aim 1, we hypothesized that 
caregivers whose children received positive ES results would report the lowest levels of 
uncertainty in all domains, and that caregivers whose children received VUS or negative ES 
results would report higher levels of uncertainty than caregivers in the positive ES group, but 
comparable levels of uncertainty to each other. For Supplemental Aim 2, we hypothesized that 
caregivers who view their child’s NDD as less permanent, less controllable, less coherent, and 
more emotionally distressing would experience greater uncertainty related to their child’s 
condition. 
Prior to the following analyses, a series of Shapiro-Wilk normality tests were run for the 
five dependent variables in this section: total weighted uncertainty (PUCHS score) and its four 
subscales (medical management, family/reproductive, social, and existential uncertainty). 
Initially, all variables violated assumptions of normality, Shapiro-Wilk p < .05. Multiple 
transformations, including exclusion of outliers, were run on each uncertainty variable to attempt 
an approximation to a normal distribution, but these were unsuccessful. Total weighted 
uncertainty exhibited a ceiling effect with a high proportion of respondents scoring at the low 
extreme of the scale (0.00), which likely accounted for its non-normal distribution. As such, the 
raw untransformed variables were used in subsequent analyses with the caveat that they deviated 





Uncertainty Experience (PUCHS Part A) vs. Importance (Part B) 
 Two one-way ANOVA were run to clarify whether inter-ES results group differences on 
uncertainty were driven by responses to Part A of the PUCHS (uncertainty experienced) or to 
Part B (importance of resolving uncertainty). The ES groups were found to be significantly 
different on Part A of the PUCHS, F(2,180) = 8.76, p < .01. However, there were no significant 
differences between ES results groups observed for Part B, F(2,180) = .70, p = .50 (see Table 
24).   
Supplemental Aim 1: Relationship Between ES Result and Domains of Uncertainty 
A series of one-way ANOVA were conducted to determine if the four domains or 
subtypes of uncertainty were different across the three ES results groups. Participants 
experienced moderate levels of uncertainty in the PUCHS components, feeling the most 
weighted uncertainty about issues related to social life and the least weighted uncertainty about 
issues related to treatment.  
For each analysis, outliers were assessed by inspection of a box-plot and homogeneity of 
variances was assessed by Levene’s test. All analyses passed the assumption of homogeneity of 
variances, shown below in Table 25(a). Post-hoc comparisons are shown in Table 25(b).  
For uncertainty related to medical management, F(2,180) = 4.13, p = .02, PUCHS 
subscale score increased from the positive (1.37 ± .94) to the negative (1.76 ± .92) and VUS 
(1.83 ± 1.12) results group, in that order, indicating the highest levels of perceived uncertainty 
for those who reported receiving VUS results (see Table 25(a)). Tukey-Kramer post-hoc 
analysis revealed a statistically significant increase from positive ES result to VUS (.45, 95% CI 




For family/reproductive uncertainty, F(2,180) = 12.92, p < .01, PUCHS subscale score 
increased from the positive (1.15 ± .93) to the negative (1.69 ± 1.03) and VUS (2.06 ± 1.04) 
results group, in that order, indicating the highest levels of perceived uncertainty for those who 
reported receiving VUS results (see Table 25(a)). Tukey-Kramer post-hoc analysis revealed a 
statistically significant increase from positive to negative ES result (.54, 95% CI (-.01 to .78), p < 
.01), as well as the increase from positive ES result to VUS (.91, 95% CI (.47 to 1.35), p < .01) 
(see Table 25(b)).  
Finally, for social uncertainty, F(2,180) = 3.55, p = .03, PUCHS subscale score increased 
from the positive ES (1.78 ± 1.33) to the negative ES (2.22 ± 1.29) and VUS (2.40 ± 1.35) 
results group, in that order, indicating the highest levels of perceived uncertainty for those who 
reported receiving VUS results (see Table 25(a)). Tukey-Kramer post-hoc analysis revealed that 
a statistically significant increase from positive to VUS (.60, 95% CI (.02 to 1.19), p = .04) (see 














Table 24. One-way ANOVA of PUCHS Parts A and B by ES results group [N = 182] 
 









(N = 81) 
Negative 
(N = 59) 
VUS 
(N = 42) 
  













8.76 <.01 Passed 




4.09 (.55) 4.12(.54) 4.02 
(.53) 
4.13(.61) .70 .50 Passed 
(p = .73) 
Note: Bolded values represent statistically significant contrasts at p ≤ .05.  
 
 
Table 25(a): One-way ANOVA of total uncertainty and uncertainty subscales by ES results 
group [N = 182] 
 









(N = 81) 
Negative 
(N = 59) 
VUS 
(N = 42) 
  












8.32 <.01 Passed 











4.13 .02 Passed 











12.92 <.01 Passed 
(p = .18) 








3.55 .03 Passed 











.38 .68 Passed 
(p = .61) 








TABLE 25(b): Tukey-Kramer post-hoc tests for pairwise comparisons of uncertainty by ES 
























95% Confidence Interval 
Lower Upper 
Total 
(From Table 17(b)) 
VUS vs. positive .60 (<.01) .16 .22 .99 
VUS vs. negative .16 (.17) .17 -.25 .57 




VUS vs. positive .45 (.04) .18 .02 .88 
VUS vs. negative .06 (.95) .20 -.40 .52 




VUS vs. positive .91 (<.01) .19 .47 1.35 
VUS vs. negative .37 (.16) .20 -.10 .83 
Positive vs. negative .54 (<.01) .17 .14 .94 
Social 
 
VUS vs. positive .60 (.04) .25 .02 1.19 
VUS vs. negative .17 (.80) .26 -.46 .79 
Positive vs. negative .44 (.13) .23 -.10 .97 
Existential N/A (no significant differences found across ES groups) 

















Supplemental Aim 2: Predictors of Total Uncertainty 
 The same dichotomous uncertainty variable from Aim 2 was used as the dependent 
variable for the logistic regression. This variable was dichotomized using a median split, wherein 
values up to and including the median value from the PUCHS (1.51) were categorized as 0/“low” 
and values greater than 1.51 were categorized as 1/“high”. The median for the sub-sample (N = 
182) was equivalent to the median of the original sample (N = 190).  
To determine which key variables would be included in the logistic regression model, a 
series of univariate logistic regression analyses between the 12 key variables of interest and the 
dichotomized uncertainty variable. Any relationships that displayed significance at p ≤ .30 were 
included in the following hierarchical regression model (see Table 26).  
A hierarchical binomial logistic regression was performed to ascertain the effects of five 
illness representation dimensions (personal control, coherence, cyclicity, emotional 
representation, and genetic attribution), the VUS-versus-negative ES results comparison, and the 
VUS-versus-positive ES results comparison on the likelihood that participants have higher levels 
of uncertainty. Multicollinearity diagnostics were run on the variables in a multiple linear 
regression analysis; because time since clinical attention and child’s age yielded a variance 
inflation factor (VIF) greater than 10, they were excluded from the logistic regression model. 
Linearity of the continuous variables with respect to the logit (log odds transformation) of the 
dependent variable was assessed via the Box-Tidwell (1962) procedure. As part of this 
procedure, all continuous predictor variables were transformed into their natural logs 
(ln(variable)). Then, interaction terms between the predictor variable and its natural log were 
created (variable * ln(variable)) and entered into the regression model along with the 




to reach statistical significance, then the assumption of linearity is upheld (Laerd Statistics 
2017b).  
In addition, as with the previous logistic regression models, a Bonferroni correction was 
applied using all 20 terms in the model resulting in statistical significance being accepted when p 
≤ .003 (Tabachnick & Fidell 2014; Laerd Statistics 2017b). Based on this assessment, all 
continuous independent variables were found to be linearly related to the logit of the dependent 
variable based on p values greater than .003. This adjusted significance level of p ≤ .003 from the 
Bonferroni correction was used to determine the statistical significance of individual coefficients 
in the logistic regression model. 
The 13 control variables were entered into the regression model in Step 1, followed by 
the seven key predictor variables in Step 2. The final logistic regression model reached statistical 
significance, χ2(20) = 65.04, p < .01. The model correctly classified 76.9% of cases. Sensitivity 
was 76.3%, specificity was 77.6%, positive predictive value was 78.2% and negative predictive 
value was 75.6%. The overall predictive power of the model improved by 8.2% (Nagelkerke R2 
40.7% to 48.9%) from Step 1 to Step 2 by adding the set of six predictor variables. 
Of the 20 independent variables, none reached statistical significance based on the 
Bonferroni adjusted p value of .003. However, two variables (coherence and caregiver’s age) 
displayed trends (see Table 27). Increasing sense of coherence for the child’s NDD was 
associated with a decreased likelihood of experiencing above-average uncertainty; in other 
words, greater coherence was associated with greater certainty. Increasing caregiver age was 
associated with a decreased likelihood of experiencing above-average uncertainty; in other 




The area under the ROC curve was .85 (95% CI, .79 to .91), which is an indicator that the 
model provides an excellent level of discrimination according to Hosmer et al. (2013). See 
Appendix G for corresponding ROC curve graph. 
 
 
Table 26. Betas and p-values for univariate logistic regressions of dichotomized uncertainty on 




Children with NDD .13 (.49) 
Child’s age -.02 (.32) 
Caregiver’s age -.03 (.04) 
Caregiver’s education -.43 (<.01) 
Caregiver’s income -.18 (.12) 
Caregiver’s gender -.10 (.84) 
PAS/PUCHS display order -.27 (.35) 
COVID caregiving -.12 (.42) 
COVID therapies .21 (.37) 
COVID financial .41 (.01) 
Child symptoms/diagnoses -.01 (.95) 
Child difficulties .00 (.94) 
Perceived seriousness -.02 (.85) 
Explanatory power -.52 (<.01) 
Chronicity  -.03 (.44) 
Consequences .01 (.77) 
Personal control  -.06 (.06) 
Treatment control -.00 (.92) 
Coherence  -.15 (<.01) 
Cyclicity  .07 (.05) 
Emotional representation  .09 (.01) 
Genetic attribution -.16 (.21) 
Time since exome testing .02 (.70) 
Time since clinical attention  -.03 (.19) 
VUS vs. positive  -1.26 (<.01) 
VUS vs. negative .75 (.02) 
 
† Relationships that are statistically significant at p ≤ .30 are bolded in the corresponding cell of the table. 
Note that all control variables (“children with NDD through “explanatory power”) were included in 






Table 27. Binomial logistic regression of uncertainty on independent variables [N = 182] 
 
Step and variable 
Dependent: Uncertainty  
B SE Wald χ2 p Odds 
Ratio 
(eB) 
95% CI for Odds 
Ratio 
Lower---Upper 
(1) Control variables 
Children with NDD 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 



































































































4.90 1.84 7.12 .01 134.32 
(2) Control + Key variables 
Children with NDD 
Caregiver’s age 
Caregiver’s education level 
Caregiver’s annual income 
Caregiver’s gender 
PAS/PUCHS display order 
COVID caregiving 
COVID therapies 










Genetic causal attribution 
ES results: VUS vs. pos 
ES results: VUS vs. neg 
Constant 


























































































































































Note: Cox & Snell R2 = .37. Nagelkerke R2 = .49. Hosmer & Lemeshow goodness-of-fit test: χ2(8) = 5.86,  
p = .66. 
Bolded values signify coefficients with p ≤ .05 considered to be trends in the data, which are discussed in more 
detail in the text. 
The variables of child’s age and time since clinical attention were initially included in regression analysis, but 






Summary of Findings  
Relationship Between ES Results and Illness Representations 
 We hypothesized that caregivers would differ in how they perceived their child’s NDD 
based on the type of ES results that were returned. Of the five predictions made about 
permanence, controllability, coherence, genetic causal attribution, and uncertainty, three were 
partially supported by the data.  
Perceptions of treatment control significantly varied across the levels of ES results in the 
order predicted: caregivers to children with negative ES results had the strongest perceptions of 
control over treatments for their child’s NDD, followed by those with VUS results and finally 
those with positive results. However, the only statistically significant difference found was 
between the means of the positive ES results and negative ES results groups. Across types of ES 
results, caregivers in our sample had fairly poor perceptions of treatment control (mean: 14.30 ± 
4.00 out of 25), lower than those of parents of children with ASD in previous research. 
Specifically, Al Anbar et al. (2010, N = 89), Gatzoyia et al. (2014, N = 111), and Mire et al. 
(2017, N = 68) reported treatment control means of 17.6 ± 3.3, 19.341 ± 2.17, and 19.68 ± 3.00 
on the IPQ-RA, respectively. These varying perceptions of treatment control between the current 
and past studies may be attributed to inherent differences in sample size and composition (e.g., 
families with ASD only vs. a range of NDD), or other factors not measured. 
 
1 For the purposes of comparison here, mean IPQ-RA scores from the study by Gatzoyia et al. (2014) 
were transformed and standardized to match the range of the traditional IPQ-R(A) (5 to 25). The original 




Caregivers’ subjective degree of coherence about their child’s condition differed between 
ES results categories, but deviated from the anticipated order. In the illness representations 
framework, coherence refers to the extent to which caregivers believe they understand their 
child’s diagnosis. Caregivers to children with positive ES results reported the highest levels of 
coherence, followed by those with negative results, and finally those with VUS results. The 
mean difference between the highest coherence ES group (positive) and the middle coherence ES 
group (negative) was statistically significant, but the difference between the negative ES group 
and the lowest coherence group (VUS) was not. Caregivers’ perceptions of coherence in our 
study fall on the lower end of the range of mean coherence scores from the three prior studies 
mentioned in the paragraph above (Al Anbar et al: 18.3 ± 4.0, Gatzoyia et al: 21.66 ± 1.81, Mire 
et al.: 16.41 ± 3.94), and reflect moderately low levels of coherence (mean: 16.75 ± 4.98 out of 
25). We can infer that obtaining a diagnosis or explanation through ES facilitates caregivers 
making sense of their child’s condition. Although not shown in the preceding data tables, this 
conclusion is supported by a statistically significant correlation between coherence and the extent 
to which caregivers endorsed the ES result as explaining their child’s differences (r(180) = .41, p 
< .001). 
 Contrary to what we expected, perceptions of NDD chronicity did not differ based on 
category of ES results, though the data did trend in the direction hypothesized. Our findings were 
inconsistent with those from past studies in which parents who received positive/diagnostic 
genetic results related to ASD saw their child’s condition as more permanent (Reiff et al. 2017). 
Caregiver perceptions of NDD permanence were notably higher across result types in our study 




3.942 out of 5, respectively). This discrepancy may be attributable to differences in measurement, 
sample characteristics, and/or time since genetic testing. Reiff and colleagues assessed 
perceptions of permanence with a single question, as opposed to the six-item IPQ-RA chronicity 
subscale in our study. Their sample was restricted to children with a clinical diagnosis of ASD, 
compared to the current study sample representing a range of NDD. Furthermore, the 
characteristics of the 2017 study sample with respect to testing timeline are unclear. The majority 
of participants had received genetic test results in the past two years. For the smaller proportion 
of respondents outside the two-year range, number of years since testing was not specified 
(stated only as “25+ months”). Time since presentation of child’s ASD symptoms was also not 
reported.  
Similarly, no significant differences were observed in perceptions of consequences, 
personal control, cyclicity, or emotional representation of the NDD. However, based on past 
research with caregivers of children with ASD, perceived permanence and perceived 
modifiability of the disorder by treatment are closely and inversely related (Reiff et al. 2017). 
Because treatment control perceptions were found to differ by ES results, our study nevertheless 
supplies evidence that ES results influence how caregivers view the capacity of therapies to help 
their child, which has potentially wide-reaching clinical implications.  
Interestingly, caregivers across the three ES results groups reported comparable 
endorsement of genetics/heredity as the cause of their child’s NDD (mean: 4.03 ± 1.16 out of 5). 
The same pattern was previously observed in parents receiving CMA results for ASD, which the 
authors reasoned was indicative of parents integrating the genetic results into their existing 
framework of causal understandings rather than constructing a new belief system (Reiff et al. 
 




2017). This suggests that it is not necessarily the belief in an underlying molecular origin for the 
NDD that drives the relationships described above. It is possible that there are cognitive and 
affective mediators that were not explicitly measured in the current study.  
 We also hypothesized that uncertainty would moderate the relationship between ES 
results and illness representations. The interaction terms in the two-way ANOVA of ES results 
by uncertainty on the IPQ-RA dimensions revealed no evidence of a moderating effect, as all 
failed to reach statistical significance. As such, it appears that the strength of the relationship 
between category of genetic test result and illness representations does not appreciably differ by 
the level of perceived uncertainty. It is also possible that the variable configuration in a true 
moderation relationship, if it exists, is distinct from that proposed in the current study. For 
example, illness perceptions could be a moderator between ES results and uncertainty. This 
prediction would be justifiable from the theoretical standpoint of the Transactional Model of 
Stress and Coping given that illness perceptions and uncertainty both constitute appraisals, and 
the literature so far is unclear as to how these constructs interrelate in the context of caring for a 
child with a chronic condition. Testing this alternate moderation hypothesis would have been 
unwieldy in our study, due to the number of distinct variables corresponding to the eight IPQ-RA 
subscales and the need to stratify each. However, future research projects could elect to use an 
abbreviated measure of illness representations, such as the Brief Illness Perception Questionnaire 
(Broadbent et al. 2006), which would facilitate the investigation of illness perceptions as a 
potential moderator between genetic results and uncertainty related to the child’s NDD. 
Relationship Between ES Results and Uncertainty 
 Mean uncertainty from the PUCHS (1.59 ± .88 [range 0 to 4]) signaled that, on the 




Levels of uncertainty were similar to those reported by Bell and colleagues (2019) (-.72 ± .78 
[range -2 to 2]) among mothers of children with Duchenne or Becker muscular dystrophy. 
However, caregivers in the current study had markedly lower average levels of uncertainty 
relative to past studies with parents of children with undiagnosed medical conditions 
(Macnamara 2014: .66 ± .76 [range -2 to 2]; Umstead et al. n.d.: .77 ± .82 [range -2 to 2]; Yanes 
et al. 2017: 3.60 ± .99 [range 1 to 5]). Thus, it is important to note that even though differences 
were found across the three ES results groups, caregivers were overall only moderately uncertain 
about the implications and significance of their child’s condition.  
Weighted uncertainty differed significantly among participants based on ES results, 
indicating that uncertainty appears to be an important illness appraisal affected by new 
information from ES testing. The ES groups fell in the expected order: caregivers who reported 
receiving a VUS experienced more uncertainty in domains that were important to them than did 
those who reported receiving negative or positive ES results. VUS results from ES are steeped in 
uncertainty, providing information about genetic changes that may or may not ultimately have 
clinical significance or provide an explanation for the child’s condition (Kiedrowski et al. 2016; 
Timmermans, Tietbohl & Skaperdas 2016). Post-hoc analyses revealed that it was the perceived 
uncertainty (measured by Part A of the PUCHS) that drove the intergroup differences, rather 
than caregivers’ perceived value of resolving different types of uncertainty (indicated by the 
weights on Part B of the PUCHS). In fact, caregivers across ES groups were similar in how they 
assessed the importance of certainty in their child’s NDD, but the degree to which they perceived 
that certainty hinged on ES findings.  
Uncertainty related to medical management was relatively low across all respondents, 




therapeutic options for their child, and can make some sense of their child’s NDD. Uncertainty 
related to family and reproductive concerns was similarly low, indicating that participants had 
some understanding of risks to relatives and how to convey this information. Uncertainty related 
to social support was higher than the previous two domains of uncertainty, though still 
moderately low, suggesting some doubt about how to connect with other parents in a similar 
situation. Finally, existential uncertainty was definitively low on average, suggesting that 
caregivers did not experience pronounced uncertainty related to the purpose or significance of 
their child’s life.  
In examining how subtypes of uncertainty varied by ES result category, we found 
differences in the medical management, family/reproductive, and social dimensions. In all three 
dimensions, uncertainty levels were highest in the group of caregivers who reported receiving a 
VUS and lowest in the group who reported positive ES results, and the difference between the 
most uncertain group (VUS) and least uncertain group (positive ES result) was statistically 
significant. No significant differences were observed between the positive and negative ES 
results groups for medical management and social uncertainty.  
Regarding uncertainty in medical management, the difference between the positive ES 
and VUS groups and lack of difference between the positive and negative ES results groups may 
be explained in part by the uniquely ambiguous, muddled nature of VUS. By definition, VUS 
represent a “residual category” of ES results interpretation: if a variant fails to meet criteria for 
pathogenic, likely pathogenic, likely benign, or benign designation, it is by default classified as 
uncertain (Timmermans, Tietbohl & Skaperdas 2016). It is possible that including “uncertain” in 
the ES result’s descriptor subconsciously heightens the recipient’s feelings of uncertainty, 




ES result classification. Similarly, there is little empiric evidence to provide further guidance on 
how outcomes differ between individuals who receive a VUS compared to a negative result from 
sequencing. Of the existing published studies, most are situated within cancer genetic counseling 
and concern either how unaffected individuals respond to uninformative results, or how 
individuals with a known familial variant respond to “true-negative” results (Medendorp et al. 
2020). Findings from these scenarios are not closely translatable to our group of caregivers, 
whose children are clinically affected and for whom no familial variant has been identified.   
Furthermore, genetic test-related communication from clinicians may be more discordant 
for families receiving a VUS compared to a negative result. Variation in how providers disclose 
VUS and outline corresponding clinical management to cancer patients has been shown to 
increase patients’ feelings of uncertainty (Makhnoon, Shirts & Bowen 2018). Although the 
authors did not assess the perspectives of patients with (non-VUS) uninformative test results, 
they suggest that this ambivalence is unique to VUS. The relevance of this observation to the 
caregivers with VUS in our sample cannot be ruled out definitively, given that we did not 
capture post-test communication practices related to findings from ES.  
Prior qualitative interviews have found that some families actively construe VUS results 
as actionable and diagnostic, either through misinterpreting the information or desiring 
actionability. For these families, the knowledge gained from ES testing, though uncertain, 
motivated them to monitor their condition more proactively (Werner-Lin et al. 2017). The 
researchers proposed that this observation may be reflective of a response to cognitive 
dissonance, which describes the incompatibility between two cognitions or beliefs. For our 
participants, we surmise that cognitive dissonance arises from tension between the awareness of 




recommendations. Families who receive a VUS from ES may be more vulnerable to cognitive 
dissonance and augmented feelings of uncertainty, compared to families who receive a 
diagnostic or a negative/uninformative result. 
Uncertainty related to the availability of social support (parents in a similar situation) was 
found to significantly differ between caregivers who received a positive ES result compared to a 
VUS. As with medical management uncertainty, no significant difference was detected between 
the positive and negative ES results groups. Social support in the context of parenting children 
with NDD has been broadly studied, with evidence underscoring its protective role in caregivers’ 
psychological wellbeing and quality of life (Halstead et al. 2018). The sense of social uncertainty 
is enhanced for families who do not get a diagnosis from genetic testing, as reflected in our 
findings that caregivers with positive results have the lowest perceptions of social uncertainty. 
Because many patient/family advocacy organizations coalesce around specific diagnoses, 
families who don’t receive a diagnostic test result may face more challenges in reaching those in 
similar circumstances. Findings from other studies affirm parents’ desire for VUS-specific peer 
support groups as a means of seeking solidarity and comfort from others (Li et al. 2018). Indeed, 
in the current study and in others focused on children with undiagnosed but suspected genetic 
conditions (Macnamara 2014; Umstead et al. n.d.), social uncertainty had the highest mean value 
of all four dimension on the PUCHS. As before with uncertainty related to medical management, 
we may speculate whether the return of genetic findings reinforces this uncertainty more acutely 
for caregivers reporting a VUS relative to a negative ES result, but the body of research at 
present does not offer any compelling explanations.   
For uncertainty related to family and reproductive issues, statistically significant 




positive and negative ES results groups. In other words, family/reproductive uncertainty was 
significantly lower among caregivers who reported receiving positive results from ES than 
among caregivers who reported receiving VUS or negative results. We posit that this finding 
relates to the inability of VUS and negative ES results to provide a precise recurrence risk that 
caregivers can share with family members or incorporate in their own reproductive planning. 
Moreover, VUS and negative ES results by definition cannot confer a genetic diagnosis, which 
may be important to caregivers when addressing their family’s questions or concerns about the 
child with NDD (Makela et al. 2009). A diagnosis often constitutes an authoritative label for a 
set of symptoms, and can allow caregivers to explain their child’s problems to others (Yanes et 
al. 2017; Neustadt 2019). For the caregivers in our study, a genetic diagnosis seemed to carry 
significance and power that a clinical or developmental diagnosis did not; the majority (73.5%,  
N = 75/102) of our respondents reporting a VUS or negative result on their child’s ES indicated 
that they had already received some kind of diagnosis from a healthcare provider.3 
Perceptions of existential uncertainty were low overall and did not differ across 
caregivers with different categories of ES results. It appears that despite experiencing uncertainty 
in other domains, caregivers did not tend to question the purpose or meaning of their child’s life. 
Their sense of certainty in the significance of their child’s life did not hinge on obtaining a 
genetic diagnosis, which coheres with findings from past research with families with 
undiagnosed medical conditions (Macnamara 2014).  
 
 
3 It is worth noting that some caregivers in our sample may have received a genetic diagnosis from CMA 
or other genetic testing prior to ES. This was possible due to clinical testing workflows at the recruitment 





Predictors of Uncertainty 
 In addition to the role of ES results, there were additional variables associated with the 
level of uncertainty expressed by participants. The analyses of variance (ANOVA) run as part of 
the moderation testing did reveal several significant associations of high-low dichotomized 
uncertainty with three illness representation dimensions. Caregivers sorted into the “high 
uncertainty” group were more likely to express that they experience low personal control, low 
coherence, and strong negative emotions related to their child’s NDD than caregivers in the “low 
uncertainty” group. These associations align with findings from several past studies. Lipinski and 
colleagues (2006) found that lower perceived personal control was a significant predictor of high 
uncertainty among parents of children with rare chromosome conditions. Furthermore, in diverse 
patient samples, illness uncertainty has been conceptually and empirically linked to emotional 
distress and mood disturbance (Mast 1998; Johnson Wright, Afari & Zautra 2009; Yanes et al. 
2017), so the association with emotional representation was not surprising. 
 We also investigated the role of illness representations in predicting caregiver uncertainty 
about their child’s NDD when adjusting for other relevant factors. In the full regression model, 
personal control and emotional representation were not predictive of uncertainty, but coherence 
and caregiver’s age tended toward an association with uncertainty. Younger caregivers in our 
sample reported higher uncertainty in their child’s NDD, in parallel with the relationship found 
by Lipinski and colleagues (2006). Younger caregivers are more likely to be inexperienced in 
parenting overall, which then amplifies their lack of knowledge when caring for a child with 
special needs. They may also be more sensitive to lack of reproductive clarity and recurrence 
risks as they contemplate having more children, whereas this concern is less salient for older 




level, income, and gender did not significantly explain variance in uncertainty, even though past 
research has found these to be influential in predicting uncertainty in similar populations (e.g., 
education level in mothers of children with ASD, Li & Lo 2016).  
Predictors of Adaptation 
 When all control variables and significant key variables were included in the regression 
model, none succeeded in reaching statistical significance based on the Bonferroni adjusted p 
value. However, trends in the data (as selected by coefficients p ≤ .05) alluded to possible 
relationships between adaptation and four variables: personal control, emotional representation, 
VUS vs. negative ES results category, and caregiver education level.   
Personal control, as operationalized in the Illness Perception Questionnaire and its 
subsequent iterations, captures caregivers’ sense that they can effect change in the course of their 
child’s neurodevelopmental condition. It can be viewed as conceptually adjacent to self-efficacy, 
as both reflect agency and actionability over a particular domain of life (e.g., a medical 
diagnosis). For the caregivers in our study, perceived control over their child’s NDD seemed to 
bear a possible connection to their adaptation to caring for an affected child. 
 An interesting trend was that caregivers in the group of individuals who reported a VUS 
more closely resembled caregivers in the positive ES group than in the negative ES group in 
terms of adaptation. In fact, category of ES results turned out to significantly predict adaptation 
in the full regression model, with caregivers in the VUS group more likely to be well adapted to 
their child’s NDD than those in the negative group.  
 In a qualitative investigation of parent perspectives of receiving a VUS from microarray 
testing, Kiedrowski and colleagues (2016) learned that participants distinguished between 




the VUS result was unclear in terms of pathogenicity, many viewed it as a tentative answer and 
the “first step toward a unifying diagnosis” (Kiedrowski et al. 2016). Similarly, Bonner (2017) 
found that some patients receiving VUS from multi-gene cancer panels felt that results were 
more pathogenic, and some less pathogenic, than the information they recalled having been 
communicated to them by the genetics provider. This subjective appraisal, driven by feeling, 
more strongly influenced participants’ risk perception than the factual clinical messaging. 
Together, observations from these two studies offer a framework for accounting for possible 
subtle differences in adaptation between participants who reported receiving VUS results and 
those who reported receiving negative results in the present study.  
Moreover, caregivers whose child received a VUS result may recognize that the result is 
inherently inconclusive and doesn’t negate the uncertainties of their child’s condition, a notion 
supported by our present findings on the elevated levels of uncertainty experienced by families 
receiving a VUS from ES. Nevertheless, these families may regard the VUS as a partial or 
possible answer, which can spur movement toward adaptation more so than for caregivers who 
receive negative ES results and have no genetic information to latch onto, no matter how 
tenuous. There is recent qualitative evidence that parents of children with ASD and a VUS on 
genetic testing report improved coping compared to families with other categories of test results 
(Lucas 2020). In addition, though it was not assessed as a separate outcome variable in our study, 
ratings of coping efficacy on the PAS were highest for caregivers whose reported a VUS 
compared to positive and negative ES results (however, these between-group differences were 
not statistically significant) [data not shown]. Further research is needed to clarify the coping and 




As we predicted, caregivers who had unfavorable feelings related to their child’s NDD, 
as measured by the IPQ-RA emotional representation subscale, reported lower adaptation. 
Persistent feelings of anxiety, anger, worry, and fear tied to a medical disorder preclude 
psychologically adapting to and accepting that disorder. Such potent affective experiences likely 
put a strain on internal coping resources and interfere with the meaning-making and integration 
processes that are central to adaptation.  
Overall uncertainty was not significantly associated with adaptation in univariate analysis 
and consequently was excluded from the multivariate regression model. We may infer that 
uncertainty in isolation does not promote or inhibit adaptation. Rather, adaptation unfolds from 
the ways that uncertainty is appraised and internalized, and this process takes place within the 
context of the family’s diagnostic odyssey. In her influential theory of uncertainty in illness, 
Mishel (1990) outlined how individuals evaluate uncertainty as either danger or opportunity, 
which in turn dictates coping response and subsequent outcomes. A previous study involving 
parents of children with undiagnosed diseases found that uncertainty was strongly negatively 
associated with coping efficacy (Macnamara 2014), a construct not measured in our study but 
theoretically residing along the pathway between appraisals and adaptation. We can imagine that 
there is a broad range of ways in which caregivers in our study construct meaning from the 
unknowns and the ambiguity in their child’s NDD. Because some conceptualize uncertainty as 
threatening and some as hopeful, and employ corresponding coping strategies, there was no 
singular predictive relationship between uncertainty and adaptation. A study with parents of 
children with ASD found a positive association between uncertainty in illness and family quality 
of life, which the author attributed to the catalytic potential of continual uncertainty in promoting 




presence of important mediating factors between the experience of uncertainty and desirable 
psychosocial outcomes.  
Importantly, there was no association found between the child’s reported functional status 
or NDD severity and caregivers’ psychological adaptation. This lack of relationship mirrors past 
research with mothers of children with Duchenne and Becker muscular dystrophy, which also 
used the PAS to quantify adaptation (Peay et al. 2016). Although a prevailing assumption may be 
that families of NDD-diagnosed children with more challenges or clinical comorbidities are 
“worse off” overall, our results suggest that the medical complexity of a child’s NDD on its own 
does not lead to poorer adaptation. In the same vein, perception of the NDD’s seriousness and of 
the explanatory power of the ES results had no significant association with adaptation in any of 
the regression models.   
Predictors of Depression, Anxiety, and Stress 
In the logistic regression models, the only key variable that was significantly associated 
with the affective outcome variables was emotional representation of the child’s NDD (p ≤ .01). 
This finding suggests that for caregivers, the negative emotional charge tied to their child’s NDD 
has bearing on their mood and mental health. Conversely, caregivers who are more prone to 
emotional distress due to psychiatric illness, situational and systemic elements, and other 
susceptibility factors may be more likely to conceptualize their child’s condition as threatening, 
overemphasize the negative aspects, and experience adverse feelings associated with the NDD as 
a result.   
For anxiety, a few control variables trended toward significance: annual income and 
COVID-related caregiving change. Respondents with higher annual income and increased 




average anxiety group. For depression, one control variable (PAS/PUCHS display order) 
emerged as a significant predictor. This unexpected finding is discussed in more depth under 
“Methodological Priming Effects” below. 
Objective and subjective measures of the child’s NDD severity did not hold up as 
predictors of emotional distress. This notion is supported by past research, in which 
characteristics of the child’s DD, epilepsy, or CP had no bearing on parents’ distress or diagnosis 
resolution when accounting for other predictors (Minnes, Perry & Weiss 2015; Pianta et al. 
1996). Rather, as these and other studies have postulated, experiences of distress and mood 
disturbance are influenced directly by coping mechanisms (e.g., reframing, positive reappraisal, 
cognitive restructuring) and coping efficacy. When choice of coping strategy is misaligned with 
the needs of the situation, or an individual’s coping reserves are completely overloaded, 
psychological wellbeing can be compromised.  
Overall, the affective outcomes we examined seem to be impervious to the NDD 
appraisals and other caregiver/child attributes that we assessed in this study, in contrast with data 
from past studies (e.g., Gatzoyia et al. 2014; Hagger & Orbell 2003). It could be that other 
dispositional or situational variables not evaluated here exert a greater influence over caregivers’ 
emotional disturbances. Furthermore, there was relatively little variance and a strong positive 
skew in the distribution of self-reported depressive, anxious, and stress symptoms among 
participants. Only a small proportion of caregivers fell within the “abnormal” or “clinical” 
(moderate to severe) range of the DASS-21 scoring guide, which is inconsistent with the mass of 
previous research showing NDD caregivers’ susceptibility to adverse mental health outcomes 
over the general population (e.g., Byrne et al. 2010; Miodrag et al. 2010; Hayes et al. 2013). 




distribution may have obscured any true predictive relationships between variables, and it is 
difficult to know whether our sample’s emotional wellbeing is truly representative of that of the 
broader population of caregivers. Conversely, differences in study design, scales, and analytic 
approach may account for the absence of significant relationships between covariates and the 
DASS-21 variables. 
Effects of COVID-19 on Respondents 
 By the time that study recruitment began in September 2020, the novel coronavirus 
(COVID-19) pandemic had disrupted daily life and healthcare service delivery for nearly six 
months. A considerable proportion of the families in our sample had endured a shelter-in-place 
order at some point since March 2020, and a sizable majority experienced total or partial 
interruption of therapies and other services for their children as a consequence. As a result of the 
pandemic, caregiving burden shifted for respondents such that most caregivers reported spending 
much more or a little more time performing caregiving tasks for their child than before COVID-
19. Nearly half of participants were not financially affected by the pandemic, and of those that 
were, few characterized these hardships as serious (see Tables 12 and 13). 
 Aside from this one trend between anxiety and COVID-related caregiving change, the 
effects of the ongoing global pandemic did not appear to confound the key relationships under 
study in the logistic regression models. However, some caution should be exercised in 
interpreting findings from our study against the backdrop of a historic and monumental public 
health crisis. Our sample may not have captured caregivers most severely impacted by 
pandemic-related difficulties, especially with respect to financial stability and livelihood. It could 
be that priorities and competing demands for time and cognitive energy deterred these caregivers 




Time as a Predictor 
 Contrary to our hypotheses, neither temporal distance from initial clinical attention nor 
from return of ES results was associated with any of the four outcome variables. Furthermore, 
adding either time variable to the regression models failed to improve the models’ Nagelkerke R2 
by more than 2% for any of the outcome variables. There are several possible explanations for 
the observed lack of association. On the one hand, families who are further from these mile 
markers have had more time to process and come to terms with the implications of their child’s 
condition. However, that elapsed time may also invite opportunities for adverse events in the 
affected child or in the family more broadly, which could lead to setbacks or stalling in the 
adaptation process. It may therefore be true that there is no linear relationship between time and 
psychological outcomes in these families. 
It is also worth noting that survey responses were heavily skewed toward recent ES 
results, with fewer caregivers representing greater elapsed time since ES was completed (see 
Figure 3 under Results). This asymmetric distribution could reflect a self-selection bias among 
respondents, in which caregivers who went through the ES process longer ago were less inclined 
to take the survey due to poor memory or decreased feelings of personal relevance. 
Methodological Priming Effects 
Depression was significantly predicted by PAS/PUCHS randomized display order (p ≤ 
.01) connoting a strong emotional priming or framing effect in which viewing the PAS second 
(directly before the DASS-21) was associated with lower depression ratings, holding all other 
variables constant. By reading statements about the ways that parenting a child with an NDD 
could be meaningful, caregivers seemed to experience a transient boost in mood that translated to 




finding may carry important implications for future survey design, especially if using similar 
measurement scales. Investigators should consider employing a counterbalancing approach like 
the one in the current study as a means to test for the presence of similar order effects. Another 
consideration is to alternate positive and negative framing between sections within a scale to try 
to neutralize its overall affective charge. However, at minimum, this would require pilot testing 
and ideally validation and reliability analyses to affirm that any semantic changes maintain the 
integrity of the measure.  
Study Limitations 
 There are several limitations in this study that merit discussion. The cross-sectional 
nature of this study does not allow for inferring causal relationships. The sample size fell short of 
our target, which likely rendered our analyses underpowered and less sensitive to relationships 
with smaller effect sizes. Even if we had attained our recruitment goal, the initial power analysis 
conducted for the study was powered to detect effect sizes (r2) around .3 to .4 in regression 
models with only one key predictor variable. As such, our extensive regression models with up 
to eight key predictor variables may have obfuscated small effects for any single key variable 
with our final sample size of 182. Some of these effects may have otherwise been detectable with 
a larger sample. Although the regression models did reveal a handful of significant predictors 
among the variables we controlled for, only one key variable (emotional representation) 
hypothesized to predict adaptation, depression, stress, and anxiety emerged as statistically 
significant. Finally, although the IPQ-RA has been validated for use with ASD, no validation 
studies have yet to be conducted for other types of NDD, such as intellectual disability and 
global developmental delay. The PUCHS and PAS have not been validated for use in families 




population in future research. Despite these constraints, the study draws strength from its 
grounding in a solid theoretical framework that enabled conceptual harmonization between 
variables of interest, guided study design, and facilitated informed interpretation of study 
findings.  
The research aims and findings are predicated on a general assumption that participants 
correctly recall their child’s ES results. Because we relied on self-report measures in lieu of 
clinically abstracted data to protect respondent anonymity, it is conceivable that participants’ 
reported ES results did not match those disclosed by their genetics team. Such discrepancies 
have been reported in previous studies, especially for individuals who receive a clinically 
uncertain result from genetic testing (Bonner 2017; Biesecker, Tibben & Vos 2019), though the 
evidence on accuracy of patient recall of ES results is mixed (Medendorp et al. 2020). We also 
did not ask about nor account for ES reanalysis, where the clinical classification of a variant can 
change over time, nor about multiple categories of findings present in a single report. In addition, 
comprehension of ES findings and confidence in recalling results were not assessed in the 
survey. With that said, prior research indicates that patients’ interpretations of their genetic 
results are better predictors of risk perception, family communication practices, and behavioral 
outcomes than the result that is actually communicated to them (Bonner 2017; Klein, Biesecker 
& Turbitt 2019). Thus, the ES result label assigned by the testing laboratory and genetics care 
team, in the absence of the caregiver’s nuanced interpretation, may be inadequate to ascertain 
which families need more support in navigating uncertainty and adapting to their child’s 
condition.  
As is the case with many similar research studies, our sample was demographically 




married, highly educated, financially well-resourced, and the biological parents to their children, 
despite the fact that the recruiting institutions serve a racially and socioeconomically diverse 
population within Baltimore. Interacting with the recruitment email and the electronic survey 
requires some degree of technological savviness, and the time demands associated with 
completing the survey may have discouraged invitees already strained for time and resources 
from participating. As a result, these findings may not be generalizable to other groups of 
caregivers of individuals with NDD.  
The validated measures used in the survey varied in terminology and language to discuss 
illness. Some referred to “symptoms,” others to “condition.” Wording was left unaltered to 
preserve the integrity of the instrument, and because it performed well during pilot testing. 
However, responses to the free-response questions at the conclusion of the survey indicated that 
this inconsistency generated some confusion for respondents.  
Practice Implications 
 Exome sequencing is rapidly gaining traction as a first-line genetic testing approach for 
neurodevelopmental disorders (Srivastava et al. 2019). Although the categories of results in ES 
are parallel to antecedent technologies like CMA, ES as a testing modality is important to 
explore because it may carry a greater weight of finality and signal a metaphorical “end of the 
road” or a diagnostic odyssey. ES is currently the most comprehensive method of genomic 
analysis readily available on a clinical basis (Blesson & Cohen 2019). As more patients with 
NDD pass through the clinical genomics pipeline and undergo diagnostic ES, genetic counselors 
who meet families should be poised and equipped to help families understand ES findings, 




work will necessarily stem from an understanding of the factors that strengthen and weaken 
caregivers’ adaptive processes.  
Our study contributes to our understanding of families of children with NDD by 
identifying several trends toward associations between adaption, caregiver characteristics, and 
illness representations. The insights from our study can help genetic counselors and other 
healthcare professionals working with these families to personalize the information, resources, 
and psychoeducational methods they use to frame a clinical encounter. Notably, three of these 
are appraisals within the Transactional Model of Stress and Coping and thus potential targets for 
therapeutic intervention in the clinic. As illness representations are schematic in nature and often 
operate subconsciously (Leventhal et al. 1980; Bishop & Converse 1986), a skillful genetic 
counselor will first help enhance a caregiver’s awareness of his or her own cognitive and 
emotional representations of the NDD. It may be beneficial for the genetic counselor to elicit the 
caregiver’s perceptions of his or her child’s differences during the pre-test session, and then 
revisit these observations at follow-up appointments to discern any changes.  
A number of potential tactics and interventions can be considered for caregivers of 
children with NDD in the pre-ES testing meeting. For all families, genetic counselors should 
delve into the personal significance of a genetic diagnosis as part of the informed consent 
conversation for ES. Bearing in mind that ES yields a genetic cause for NDD in fewer than half 
of cases, an important piece of anticipatory guidance is to explore families’ current causal beliefs 
about their child’s NDD, and how expect they will respond to an unrevealing outcome. On the 
affective side, genetic counselors may also encourage caregivers to reflect on feelings related to 




psychotherapy for the individual caregiver, the couple, or the family may be indicated if adverse 
feelings related to the child’s NDD are persistent and psychically taxing. 
Perceptions of personal control may be bolstered through deliberate assessment and 
conversation with caregivers that combines strengths-based and solution-focused techniques. The 
genetic counselor can use a progressive framework of questions, such as that outlined by White 
(2002): externalizing (determining how the problem has attempted to control the client’s life), 
landscape-of-action (identifying times when the client feels he or she has control over the 
problem), landscape-of-consciousness (reflecting on how the client has actually solved problems 
and recognized his or her ability to do so), and future-oriented (focusing on potential solutions). 
Through these questions, the counselor invites dialogue about the ways in which caregivers 
believe they can help their children navigate their condition, and jointly strategizes with them on 
means of boosting control and self-efficacy. As suggested by previous research in other medical 
settings, it may benefit caregivers to examine their beliefs around internal vs. external health 
locus of control, which has shown promise as a target for intervention with postpartum women 
(Moshki et al. 2013) and adults with chronic pain (Coughlin et al. 2000). Although both studies 
employed longer-term programs consisting of sessions spanning several weeks, similar 
principles may be adapted to a short-term genetic counseling format; this would require further 
evaluation through experimental designs.  
Successful interventions have also been deployed to promote client empowerment,4 a 
construct closely related to perceived personal control and a key outcome for genetic counseling 
(Yuen et al. 2019). Shearer and colleagues (2007) demonstrated that an empowerment 
 
4 Empowerment is defined as “a set of beliefs that enable a person from a family affected by a genetic 
condition to feel that they have some control over and hope for the future” (McAllister, Dunn & Todd 




intervention delivered over the phone by nurses, which focused on goal attainment and solutions 
to health concerns, facilitated self-management of heart failure among diagnosed patients. 
Although there is recent evidence that the process of genetic counseling itself enhances 
empowerment (Ison et al. 2019), genetic counselors can maximize its benefits to families with 
NDD by tackling specific cognitive representations during the visit.  
In the results disclosure visit and following sessions, genetic counselors should be 
attuned to how particular NDD representations differ across types of ES results and adjust their 
session goals accordingly. For example, knowing that families that receive a positive ES finding 
are prone to lower perceived treatment control can prompt the counselor to probe what 
“treatment” looks like to the child’s caregivers. For some caregivers, outlining the wide range of 
treatment approaches may help broaden their views of what could be effective, and generate 
ideas for personalized resources that the genetic counselor can provide. This discussion could 
involve highlighting different treatment modalities (e.g., biomedical, behavioral, speech/ 
language) and settings (school, home) (Mire et al. 2017). 
Conceptualizing uncertainty as nuanced and multi-faceted may help genetic counselors 
and other healthcare professionals to deepen their psychosocial work with families. Irrespective 
of the outcome of genetic testing, clinicians should assess and attend to the ways in which the 
lack of closure or uncertainty resolution impacts NDD caregivers’ overall coping and 
functioning. Offering labels or categories for uncertainty, such as those presented in the PUCHS, 
can be empowering in expanding the language that caregivers have to discuss their experiences. 
If feasible within the clinical structure and workflow, families that receive non-diagnostic results 
from ES may warrant periodic follow-up from genetic counselors or other providers. 




patient families and support organizations, thereby reducing social support-related uncertainty 
and enhancing potential outcomes like life satisfaction and positive affect (Halstead et al. 2018).   
 For certain types of ES results, attention to specific domains of uncertainty may be 
warranted. As indicated by the current findings, caregivers receiving different kinds of results 
from ES diverge along uncertainty dimensions as well as in overall perceptions of uncertainty. 
For instance, families that receive VUS results from ES may be more susceptible to uncertainty 
regarding prognosis, reproductive risks, and social support than families receiving positive or 
negative results. A genetic counselor can keep on-hand an arsenal of resources designed to help 
these caregivers work through types of uncertainty that are most relevant and important to them. 
For example, if the client is unsure how to talk about the ES results with family members, the 
counselor could lead a role-play that allows the client to practice and gain confidence in 
delivering the information. If a caregiver is at a loss for where to seek support, the counselor may 
refer to a list of other families in the clinic with VUS results to make an introduction. 
Importantly, the more cognizant providers are of the varied sources and expressions of 
uncertainty, the better equipped they will be to provide individualized care to their families.   
Areas for Future Research 
 Our study elucidated several potential relationships between caregivers’ psychological 
state and the ways in which they view their child’s NDD. However, as discussed above, the 
cross-sectional study design limited our analyses and the conclusions we can draw. A recent 
study with families with ASD queried parental perceived benefits of diagnostic genetic testing 
before and after return of results, but this was not a within-subjects design and thus 
uninformative about change in perception over time (Lucas 2020). Future projects with a more 




population, capturing caregivers’ pre-test expectations, hopes, and NDD perceptions to compare 
to post-test experiences over several follow-up interviews. Appraisal, coping, and adaptive 
processes are construed as dynamic and responsive, and this type of repeated measures design 
could allow for better isolation of the genetic result disclosure as a stressor that alters caregiver 
appraisals. It would also open up opportunities to understand what appraisals are formed about 
the ES result itself; this segment of the TMSC pathway was not evaluated in our study. Recent 
evidence points to the pivotal role of hope fulfillment in psychological adaptation as it relates to 
clinical genomic results (Griesemer et al. 2019), which could be examined alongside illness 
representations in better understanding NDD caregiver adaptation. This would necessitate a 
purposeful assessment of what aspects of hope are most pertinent to caregivers as they await ES 
results, perhaps through a qualitative design.  
 On the clinical side, little has been studied about provider communication during ES 
results disclosure. It is reasonable to suspect that the language and messaging used by healthcare 
professionals may influence caregivers’ illness representations, feelings of uncertainty, and 
constructed meaning of genetic results. Although some ideas were proposed in the previous 
section, few targeted interventions have actually been tried and evaluated. Haakonsen Smith and 
colleagues (2018) demonstrated that a short-term, individualized coping effectiveness training 
was feasible and beneficial for parents of children with ASD within a genetic counseling setting. 
Assessment of novel counseling interventions through randomized controlled trials would assist 
in determining which types of therapeutic strategies, such as those informed by cognitive 
behavioral therapy (CBT), are efficacious and practicable for caregivers of individuals with 




 Although this study measured multiple dimensions of time, including length of time since 
initial developmental concerns and length of time since first seeking clinical attention, we did not 
ask caregivers about genetic testing their child had prior to ES. Future research might explore 
whether similar predictors of adaptation surface between families who received ES as first-line 






















APPENDIX A: Glossary of Abbreviations  
• ADHD: attention deficit hyperactivity disorder 
• ASD: autism spectrum disorder(s) 
• CBT: cognitive behavioral therapy  
• CDC: Centers for Disease Control and Prevention  
• CMA: chromosome microarray analysis  
• CP: cerebral palsy  
• DASS-21: Depression Anxiety Stress Scale—21 Item 
• DBD: developmental brain dysfunction  
• DD: developmental delay or disability 
• ES: exome sequencing 
• GDD: global developmental delay 
• GS: genome sequencing 
• ID: intellectual disability 
• IPQ: Illness Perception Questionnaire 
• IPQ-R(A): Revised Illness Perception Questionnaire (for Autism) 
• JHM: Johns Hopkins Medicine 
• KKI: Kennedy Krieger Institute  
• NDD: neurodevelopmental disorder(s) 
• PAS: Psychological Adaptation Scale 
• PUCHS: Parental Uncertainty about a Child’s Health Scale 
• SRMIR: Self-Regulatory Model of Illness Representation 
• TMSC: Transactional Model of Stress and Coping 
• VUS: variant(s) of uncertain (or unknown) significance  











APPENDIX B: Variable Dichotomization Scheme for Logistic Regression Analysis 
 
 










Low (N) High (N) 
Adaptation (PAS) Mean 0 – 20 3.75 87 96 
Depression (DASS-
21) 
Scale scoring guide† 0 – 42 9 131 52 
Anxiety (DASS-21) Scale scoring guide† 0 – 42 7 142 41 
Stress (DASS-21) Scale scoring guide† 0 – 42 14 113 70 
Weighted uncertainty 
(PUCHS) 
Median 0 – 4 1.51 91 91 


































































APPENDIX E: Survey Instrument 
Before we begin, we have a few questions that will determine whether you are eligible to join 
this study. 
1. Are you primary caregiver to an individual with a neurodevelopmental disorder? 
[Response required] 
a. Yes 
b. No * 
2. Is this individual still living? [Response required] 
a. Yes 
b. No * 
3. Are you 18 years or older? [Response required] 
a. Yes 
b. No * 
4. Were you invited to participate in this study by a genetics provider at Kennedy Krieger 
Institute or Johns Hopkins Medicine? [Response required] 
a. Yes 
b. No * 
5. To your knowledge, has anyone else in your household already completed this survey? 
[Response required] 
a. Yes * 
b. No 
 
* indicates responses that would trigger the survey to exit and redirect respondent to “Ineligible” 
end page  
 
 
Thank you for taking part in this survey. Throughout the questions you will read, NDD stands for 
“neurodevelopmental disorder.” This includes conditions such as autism spectrum disorder 
(ASD), intellectual disability (ID), developmental delay (DD), cerebral palsy (CP), movement 
disorders, and others. 
 
You were invited to take this survey because your child had a genetic test called exome 
sequencing, or exome testing. This test looked at all of the known genes that might be related to 
their NDD. The test can tell if there are any changes in those genes that could explain your 
child’s condition.  
 
About Your Child and Your Family 
 
First, we would like to learn a little more about your child and family.  
 
1. How many children do you have with some kind of NDD? _______ 
 
2. How many children do you have who have had exome testing for an NDD? ______  
 
If your answer to Question #2 was more than 1, please answer the following questions on this 






3. Did you already receive results from your child’s exome testing? [Response required] 
a. Yes 
b. No * 
* indicates response that would trigger the survey to exit and redirect respondent to “Results 
Disclosure Pending” end page  
 
4. How old is your child currently? If your child is under 1 year of age, please enter 0.  
________ years   
 





6. How old was your child when you first had concerns about their behavior or 
development?  
________ years  ________ months 
 
7. How old was your child when you sought out a behavioral or medical specialist about 
your concerns for your child’s development? This may have been a pediatrician, early 
intervention specialist, neurologist, psychologist, or other provider. If your child was 
under 1 year of age, please enter 0. 
_______  years 
 
8. Has a provider given you a diagnosis for your child’s neurodevelopmental differences? 
a. Yes 
b. No 
c. I’m not sure 
 





10. As far as you know, does your child have other family members with a known/diagnosed 
NDD? This includes your child’s parents, siblings, nieces/nephews, cousins, 




11. What is your relationship to your child? 
a. Biological parent 
b. Adoptive parent 
c. Foster parent 
d. Grandparent 
e. Stepparent  






12. Does your child live at home with you?  
a. Yes, all the time 
b. Yes, part of the time 
c. No 
 
13. How long have you been in the caregiving role for your child?  
a. His/her whole life 
b. Most of his/her life 
c. About half of his/her life 
d. Less than half of his/her life 
 
14. Do you have a partner in providing care for your child?  
a. Yes, all the time 




About Your Child’s Genetic Testing for NDD 
 
15. How old was your child when you received results from exome testing? If your child was 
under 1 year of age, please enter 0.  
a. _______ years 
b. I don’t know how old my child was 
 
16. How much do you feel the exome findings explain your child’s neurodevelopmental 
differences?  
a. Not at all 









17. What was the outcome of exome testing in your child?  
a. Positive (abnormal): the test found a gene change that is the cause of my child’s 
NDD 
b. Negative (normal): the test did not find any gene changes related to my child’s 
NDD 
c. Variant of uncertain significance (VUS) (inconclusive): the test found a change in 
one of my child’s genes, but it is unclear whether this change is related to my 
child’s NDD 
d. I’m not sure 
 
18. Where did you see the doctor who ordered your child’s genetic testing? 
a. Kennedy Krieger Institute 
b. Johns Hopkins Medicine  






About Your Child’s NDD 
 
Next, please check the boxes below that describe problems that your child experiences. Check 
as many as apply to your child.  
 
[  ] Autism / autism spectrum disorder  
[  ] Intellectual disability 
[  ] Developmental delay 
[  ] Cerebral palsy  
[  ] Movement disorder 
[  ] Epilepsy / seizures  
[  ] Birth defects  
[  ] Other neurological problem 
      Please describe: _____________________ 
 
Please check the boxes below that describe tasks, skills that your child needs help with. Check 
as many apply to your child. This is to help us better understand your child’s functioning with 
his/her NDD.  
 
[  ] Moving around at home, school and/or community 
[  ] Using his/her hands and arms to do the things he/she wants to do 
[  ] Performing functions such as feeding/eating 
[  ] Toileting 
[  ] Dressing or undressing self 
[  ] Sleeping each night 
[  ] Seeing  
[  ] Hearing 
[  ] Understanding other people 
[  ] Telling people what he/she wants 
[  ] Behaving in an appropriate manner 
[  ] Regulating his/her mood 
[  ] Managing his/her pain  
[  ] Learning new things 
[  ] Remembering things they know 
[  ] Getting along with other children 
[  ] Getting along with adults 
[  ] Participating in activities at home 
[  ] Participating in activities at school or in the community  
 
How serious is your child’s condition compared with other children with an NDD? 
a. Much less severe than other children with an NDD 
b. Somewhat less severe than other children with an NDD 
c. No more or less severe than other children with an NDD 
d. Somewhat more severe than other children with an NDD 






Next, we are interested in your own personal views of how you now see your child’s condition. 
Please tell us how much you agree or disagree with the following statements about your child’s 
condition by clicking the appropriate button for each statement. 
 





Agree Strongly Agree 
1. My child’s condition will last a short time.      
2. My child’s condition is likely to be 
permanent rather than temporary.       
3. My child’s condition will last for a long time.      
4. My child’s condition will pass quickly.  
      
5. I expect my child to have this condition for 
the rest of his/her life.      
6. My child’s condition is a serious condition.      
7. My child’s condition has major 
consequences on my life.       
8. My child’s condition does not have much 
effect on my life.       
9. My child’s condition strongly affects the 
way others see me.       
10. My child’s condition has serious financial 
consequences.      
11. My child’s condition causes difficulties for 
those who are close to me.       
12. There is a lot I can do to control my 
child’s symptoms.       
13. What I do can determine whether my 
child’s condition gets better or worse.       
14. The course of my child’s condition 
depends on me.       
15. Nothing I do will affect my child’s 
condition.       
16. I have the power to influence my child’s 
condition.      
17. My actions will have no effect on the 
outcome of my child’s condition.       
18. My child’s condition will improve in time.       
19. There is very little that can be done to 
improve my child’s condition.      
20. My child’s treatment will be effective in 
curing his/her condition.      
21. The negative effects of my child’s 
condition can be prevented (avoided) by 
his/her treatment.  




22. My child’s treatment can control his/her 
condition.       
23. There is nothing that can help my child’s 
condition.       
24. The symptoms of my child’s condition are 
puzzling to me.       
25. My child’s condition is a mystery to me.      
26. I don’t understand my child’s condition.      
27. My child’s condition doesn’t make sense 
to me.      
28. I have a clear picture or understanding of 
my child’s condition.      
29. The symptoms of my child’s condition 
change a great deal from day to day.       
30. My child’s symptoms come and go in 
cycles.      
31. My child’s condition is very unpredictable.       
32. My child goes through cycles in which 
his/her condition gets better and worse.       
33. I get depressed when I think about my 
child’s condition.       
34. When I think about my child’s condition, I 
get upset.      
35. My child’s condition makes me feel angry.      
36. My child’s condition does not worry me.       
37. That my child has his/her condition 
makes me feel anxious.      























We are interested in what you consider may have been the cause of your child’s condition. As 
people are very different, there is no correct answer for this question. We are most interested in 
your own views about the factors that caused your child’s condition rather than what others 
including doctors or family may have suggested to you. Below is a list of possible causes for 
your child’s condition. Please indicate how much you agree or disagree that they were causes 
for you by ticking the appropriate box. 
 





Agree Strongly Agree 
Stress or worry      
Genetics / heredity      
A germ or virus      
Vaccines      
My child’s diet or eating habits      
Chance or bad luck      
Poor medical care in my child’s past      
Pollution in the environment      
My own behavior      
God’s will      
Medical error       
Accident or injury       
My child’s aging       
Deterioration of my child’s immune system      
Pregnancy complication or birth injury       
Head trauma       
Early childhood illness       
Antibiotic or medication taken by my child      
 
On the lines below, please list in rank-order the 3 most important factors that you now believe 
caused your child’s condition. You may use any of the items from the list above, or you may 
have additional ideas of your own. 
 












Next, please think about how being a caregiver to a person with an NDD has impacted your life. 
Please click the button for how much you agree or disagree with the following statements. 
 
Being a caregiver of an individual with an NDD has… 
 









1. …helped me accept the way things 
work out.      
2. …helped me learn to deal better with 
uncertainty.      
3. …taught me how to adjust to things I 
cannot change.      
4. …helped me take things as they come.      
5. …helped me to look at things in a more 
positive way.      
6. …helped me learn to handle difficult 
times.      
7. …helped me become more comfortable 
with who I am.      
8. …helped me become a stronger person.       
9. …helped me feel better about my ability 
to handle problems.      
10. …helped me become a better person.       
11. …helped me know who I can count on 
in times of trouble.       
12. …makes me more willing to help 
others.      
13. …helped relationships become more 
meaningful.       
14. …helped me become closer to people 
I care about.       
15. …helped me become more aware of 
the love and support available from other 
people. 
     
16. …helped me learn my life is more 
meaningful.       
17. …given me a greater appreciation for 
life.      
18. …helped me develop a deeper sense 
of purpose in life.      
19. …helped me feel peaceful.       
20. …helped me find strength in my faith 






Next, we’d like to hear about your experience with uncertainty related to your child’s condition.  
 
In Part A, please mark how much you agree with each statement by clicking the corresponding 
button. In Part B, please mark how important each type of certainty is to you by clicking the 
corresponding button.  
 
PART A: Having a genetic diagnosis or not having a genetic diagnosis for my child’s condition 
leaves me… 
 
 Strongly Disagree Disagree Unsure Agree 
Strongly 
Agree 
1A: …with no clear understanding of my 
child’s limitations      
2A: …unsure how to think about my child’s 
condition      
3A: …unsure of whether my child is expected 
to have a normal lifespan      
4A: …anticipating my child may do better 
than anyone has anticipated      
5A: …insufficiently prepared to participate in 
treatment decisions for my child      
6A: …unsure where to go for treatment of my 
child’s condition      
7A: …lacking information to make decisions 
about having more children      
8A: …unsure what to tell relatives about risks 
to their children      
9A: …unprepared to inform my children about 
risks to their children      
10A: …ill-prepared to make decisions for my 
family not knowing what the future may hold 
for my child 
     
11A: …less able to address my family’s 
concerns about my child      
12A: …struggling to find parents in a similar 
situation      
13A: …without support from parents going 
through similar experiences      
14A: …uncertain about the meaning of my 
child’s life      
15A: …questioning the purpose of my child’s 
















Neutral Somewhat important Important 
1B: Having a clear understanding of my 
child’s limitations      
2B: Having a background against which 
to think about my child’s condition      
3B: Being sure that my child is expected 
to have a normal lifespan        
4B: Anticipating that my child may do 
better than has predicted      
5B: Being prepared to participate in 
treatment decisions for my child      
6B: Knowing where to go for treatment of 
my child’s condition      
7B: Having information to make decisions 
about having more children      
8B: Knowing what to tell relatives about 
risks to their children      
9B: Being prepared to inform my children 
about risks to their children      
10B: Being able to make decisions for my 
family not knowing what the future may 
hold 
     
11B: Addressing my family’s concerns 
about my child      
12B: Finding parents in a similar situation      
13B: Having support from parents going 
through similar experiences      
14B: Having clarity about the meaning of 
my child’s life      
15B: Understanding the purpose of my 



















Next, we have a few questions about how you’ve been feeling recently. Please read each 
statement and click the number 0, 1, 2 or 3, which indicates how much the statement applied to 
you over the past week. There are no right or wrong answers. Do not spend too much time on 
any statement. 
 
The rating scale is as follows: 
0 -- Did not apply to me at all 
1 -- Applied to me to some degree, or some of the time 
2 -- Applied to me to a considerable degree or a good part of time 
3 -- Applied to me very much or most of the time 
                                                                                           Not at all                                Most of the 
time 
1. I found it hard to wind down. 0             1             2             3  
2. I was aware of dryness of my mouth.  0             1             2             3 
3. I couldn’t seem to experience any positive feeling at 
all.  
0             1             2             3 
4. I experienced breathing difficulty (e.g. excessively 
rapid breathing, breathlessness in the absence of 
physical exertion) 
0             1             2             3 
5. I found it difficult to work up the initiative to do 
things. 
0             1             2             3 
6. I tended to overreact to situations. 0             1             2             3 
7. I experienced trembling (e.g. in the hands). 0             1             2             3 
8. I felt that I was using a lot of nervous energy. 0             1             2             3 
9. I was worried about situations in which I might panic 
and make a fool of myself. 
0             1             2             3 
10. I felt that I had nothing to look forward to.  0             1             2             3 
11. I found myself getting agitated.  0             1             2             3 
12. I found it difficult to relax.  0             1             2             3 
13. I felt down-hearted and blue. 0             1             2             3 
14. I was intolerant of anything that kept me from getting 
on  
with what I was doing. 
0             1             2             3 
15. I felt I was close to panic. 0             1             2             3 
16. I was unable to become enthusiastic about anything. 0             1             2             3 
17. I felt I wasn’t worth much as a person.  0             1             2             3 













19. I was aware of the action of my heart in the absence 
of physical exertion (e.g. sense of heart rate 
increase, heart missing a beat). 
 
0             1             2             3 
20. I felt scared without any good reason. 0             1             2             3 
21. I felt that life was meaningless.  0             1             2             3 
 
 
Next, we’d like to learn a little more about you.  
 
1. What is your current age? ________  
 





3. What is your race? Check all that apply.  
a. American Indian/Alaska Native 
b. Asian 
c. Black/African American 













e. Partnered but not married 
f. Other 
 
6. How would you describe your current employment status?  
a. Employed, full-time 






7. What is your highest level of education completed? 
a. Elementary or junior high school 
b. High school/GED 




d. Some college 
e. Completed college 
f. Graduate degree 
 
8. What is your annual household income? 
a. Under $30,000 
b. $30,000 - $50,000 
c. $50,001 - $70,000 
d. $70,001 - $100,000 
e. $100,001 - $250,000 
f. Above $250,000 
 
 
The COVID-19 (coronavirus) outbreak has changed daily life for families across the country and 
around the world. We would like to hear a little about how the pandemic has affected your 
family. This will help us to better understand your answers to other questions in this survey.  
 




c. I don’t know 
 




[If “YES” to Q2] 3. For how many months have you been sheltering in place? _______ 
 
[If “NO” to Q3] 4. For how many months were you sheltering in place? ________ 
 
5. In thinking about the time before COVID-19 compared to now, how has your caregiving 
situation changed? 
a. I spend much more time performing activities related to caring for my child now 
than before COVID-19 
b. I spend a little more time performing activities related to caring for my child now 
than before COVID-19 
c. I spend the same amount of time performing activities related to caring for my 
child now as I did before COVID-19 
d. I spend a little less time performing activities related to caring for my child now 
than before COVID-19 
e. I spend much less time performing activities related to caring for my child now 
than before COVID-19 
 
6. Have you had any interruption of therapies or other services for your child due to 
COVID-19? 
a. Yes, all services were interrupted 
b. Yes, some services were interrupted 
c. No, none of my child’s services were interrupted 





7. Have you had financial difficulties due to COVID-19? 
a. Yes. We have experienced serious financial challenges. 
b. Yes. We have experienced some financial challenges that I would not consider to 
be serious. 
c. Yes. There have been minor negative effects on our financial situation. 
d. No. Our financial situation has not been affected by COVID-19. 
e. I don’t know yet whether or not we will face financial challenges related to 
COVID-19. 
f. I prefer not to answer.  
 
 
We will end by hearing from you about your overall experience. In your responses below, please 
be sure to not include any identifying information about your child.  
 
1. In a few sentences, please share how exome testing has had a positive impact on your 
life, if at all.  
 
2. Please share how exome testing has had a negative impact on your life, if at all. 
 
3. Think back to when you decided for your child to have exome testing but hadn’t received 
the results yet. What were your hopes and expectations for the testing? 
 
4. Thinking about the impact of the COVID-19 pandemic on your family, how different do 
you imagine your responses to the survey questions would be if you had answered 
before the pandemic? 
a. Extremely different 
b. Very different 
c. Somewhat different 
d. Slightly different 
e. No different  
 
















Thank you for taking the time to complete this survey. We appreciate you sharing 
your thoughts with us and helping us to better understand the experience of 
caregivers of children with neurodevelopmental disorders. 
 
If you would like to receive a $5 Amazon gift card in exchange for your time, 
please click the link below. This will take you to an external page with a form, 
where you can enter your email address. Your email address will not be 




If you have any questions about information presented in this study, you can 
reach out to the researchers or contact the Johns Hopkins Bloomberg School of 
Public Health IRB Office. 
 
Amelia Mulford, BA 
Student Investigator / Associate Investigator 




Lori Erby, PhD, ScM, CGC 
Primary Associate Investigator 
National Human Genome Research Institute  
Bethesda, MD 
Phone: 301-443-2635 
Email: lori.erby@nih.gov  
 
Debra Roter, DrPH 
Principal Investigator 




Johns Hopkins Bloomberg School of  
Public Health IRB Contact Information: 
Telephone: 410-955-3193 




If you need to talk to someone about any feelings or questions that were brought 
up because of this study, please contact the research team or utilize the following 
resources: 
 
National Alliance on Mental Illness Helpline - 1-800-950-NAMI (6264) 
National Alliance on Mental Illness Crisis Text Line - Text NAMI to 741-741 
 
If you would like to reach out and connect with other families of individuals with 
disabilities, you can find a list of support resources below: 
 
• Understood (national): http://www.understood.org  
• The Arc (regional): https://thearc.org/  








APPENDIX F: Factor Loadings for PUCHS and PAS 
 
 
Table 1. Factor loadings for the PUCHS 
 








1. …with no clear understanding of my child’s 
limitations. 
.79 -.04 .02 .01 
2. …unsure how to think about my child’s 
condition. 
.88 -.08 -.03 .03 
3.* …unsure of whether my child is expected to 
have a normal lifespan.  
.30 .07 .32 .05 
4.* …anticipating my child may do better than 
anyone has anticipated. 
.11 .04 .09 -.02 
5. …insufficiently prepared to participate in 
treatment decisions for my child. 
.43 .22 .01 .04 
6. …unsure where to go for treatment of my 
child’s condition. 
.48 .15 .04 .08 
7. …lacking information to make decisions 
about having more children. 
.12 .44 -.09 .18 
8. …unsure what to tell relatives about risks to 
their children. 
-.10 .97 .01 -.01 
9. …unprepared to inform my children about 
risks to their children. 
-.01 .81 .05 -.03 
10. …ill-prepared to make decisions for my 
family not knowing what the future might hold 
for my child. 
.23 .37 .17 .16 
11. …less able to address my family’s concerns 
about my child. 
.29 .54 .14 .03 
12. …struggling to find parents in a similar 
situation. 
-.03 -.02 .98 .02 
13. …without support from parents going 
through similar experiences. 
-.02 .01 .90 .08 
14. …uncertain about the meaning of my child’s 
life. 
.05 .02 -.04 .94 
15. …questioning the purpose of my child’s 
life. 
-.05 -.03 .09 .88 
* Item excluded from scale following factor analysis 
Note: Highlighted values indicate which factor (or component) the item is part of. Factor loadings 












Table 2. Factor loadings for the PAS 
 
 









1. …helped me accept the way things work out. 
 
.63 .03 .12 -.14 
2. …helped me learn to deal better with 
uncertainty. 
.81 -.07 -.06 -.04 
3. …taught me how to adjust for things I cannot 
change 
.95 .03 -.10 .03 
4. …helped me take things as they come. 
 
.88 .07 -.00 -.01 
5. …helped me to look at things in a more 
positive way. 
.34 -.22 .03 -.30 
6. …helped me learn to handle difficult times. 
 
.40 -.34 .04 -.14 
7. …helped me become more comfortable with 
who I am. 
.26 -.28 .01 -.33 
8. …helped me become a stronger person.  
 
.01 -.73 .02 -.21 
9. …helped me feel better about my ability to 
handle problems. 
.11 -.76 .01 -.04 
10. …helped me become a better person.  
 
.02 -.58 .16 -.19 
11. …helped me know who I can count on in 
times of trouble.  
.19 -.27 .42 .21 
12. …makes me more willing to help others. 
 
.02 -.28 .45 -.05 
13. …helped relationships become more 
meaningful.  
-.05 -.00 .92 -.06 
14. …helped me become closer to people I care 
about.  
-.02 .18 .83 -.22 
15. …helped me become more aware of the 
love and support available from other people. 
.07 -.07 .62 -.05 
16. …helped me learn my life is more 
meaningful.  
.09 -.14 .05 -.73 
17. …given me a greater appreciation for life. 
 
.17 -.16 .08 -.58 
18. …helped me develop a deeper sense of 
purpose in life. 
.02 -.16 .02 -.72 
19. …helped me feel peaceful.  
 
.06 .05 .08 -.73 
20. …helped me find strength in my faith or 
spiritual beliefs.  
.06 .00 .12 -.53 






APPENDIX G: Scatterplots for Investigation of Linear Relationships Between Adaptation 


















































APPENDIX H: ROC Curves for Logistic Regression Models 
 
Figure 1. ROC curve for the logistic regression with adaptation as the dependent variable. 
 





Figure 3. ROC curve for the logistic regression with anxiety as the dependent variable. 
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